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resumo 
 
 
O ambiente hospitalar é caracterizado por uma grande diversidade de 
diferentes espécies bacterianas, as quais podem tornar-se resistentes a 
antibacterianos. Apesar da natureza específica de efluentes hospitalares, estes 
são considerados com a mesma carga poluente e como constituintes das 
águas residuais urbanas, sendo descarregados para redes de esgotos urbana, 
recolhidos e cotratados com os efluentes municipais na ETAR. 
O objetivo do estudo consistiu em avaliar a estrutura das comunidades 
microbianas e determinar a ocorrência e abundância de genes relacionados 
com resistência a antibióticos (blaCTX-M, blaVIM, blaTEM, blaSHV e intl1) de 
efluentes hospitalares (internamento e laboratório de microbiologia) e efluentes 
urbanos (pré e pós-tratamento na ETAR de Cacia). Procedeu-se com a análise 
por DGGE e por PCR quantitativa. 
As amostras foram colhidas em duas estações diferentes, revelando as 
diferenças na estrutura da comunidade bacteriana. As comunidades dos 
efluentes das hospitalizações e dos efluentes de pré e pós-tratamento ficaram 
agrupadas no mesmo cluster, enquanto as comunidades predominantes nos 
efluentes do laboratório de microbiologia localizaram-se num outro cluster. Os 
cinco genes selecionados estavam presentes em todos os efluentes. Os 
efluentes hospitalares tiveram a maior abundância total dos genes do que os 
efluentes urbanos. De todos os genes, blaVIM teve uma abundância notável 
devido a sua alta abundância de águas residuais nas hospitalizações e 
enfermarias, seguido por Intl1. blaCTX-M, blaTEM e blaSHV  demonstraram 
abundancias mais baixas. No que diz respeito ao tratamento biológico aplicado 
na ETAR de Cacia, uma vez que a abundância de genes foi menor após o 
tratamento, é previsível que o tratamento possa ser moderadamente eficaz. 
Os nossos resultados mostram que os ambientes hospitalares tendem a ser 
um ambiente complexos devido à elevada diversidade microbiana, às pressões 
seletivas criadas pelo uso de antimicrobianos e pelos eventos de transferência 
lateral de genes. A rede de esgotos urbanos e da ETAR de Cacia representam 
reservatórios de resíduos de antibióticos, determinantes de resistência a 
antibióticos e bactérias resistentes a antibióticos. 
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Abstract 
 
 
 
 
 
 
 
 
 
 
Hospital environment is characterized by multiplicity of different bacterial 
species, which some of them can become resistant to antibacterial. Despite the 
specific nature of hospital effluents, they are considered to be the same 
pollutant and constituent load as urban wastewaters, being discharged to public 
sewage networks, collected and co-treated with the urban effluents in the 
WWTPs. 
The aim of the study was to evaluate structure of microbial communities and to 
determinate the occurrence and abundance of genes associated with antibiotic 
resistance (blaCTX-M, blaVIM, blaTEM, blaSHV and intl1) of Hospital wastewaters 
(hospital wards and microbiology laboratory) and urban effluents (pre- and 
post-treatment of WWTP of Cacia). DGGE and qPCR were performed.  
The samples were collected in two different seasons, revealing differences in 
bacterial structure community. Hospitalizations and pre-and post-treatment 
communities were grouped in the some cluster, while microbiology laboratory 
communities were located in other cluster. The five genes selected were 
present in all effluents. The hospital wastewaters had the highest total 
abundance of the genes than the urban effluents. Of all genes blaVIM had a 
notable abundance due its high abundance in hospitalizations wastewater, 
followed by intl1. blaCTX-M, blaTEM, blaSHV had the lowest abundances. Regarding 
with the biological treatment applied in the WWTP of Cacia, once the 
abundance of the genes was lower after the treatment, it is predictable that the 
treatment can be moderately effective. 
Our results show that hospital settings tend to be an environment complex due 
the high microbial diversity of commensal and nosocomial pathogenic, the 
selective pressures created by antimicrobial use and the events of lateral gene 
transfer. The urban sewage network and the WWTP of Cacia represent a 
receptor of antimicrobial residues and antibiotic-resistance bacteria. 
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1. Introduction 
There are millions of species in the prokaryote domains, Bacteria and Archaea. Several 
studies related with the quantification of abundance and diversity of Bacteria and 
Archaea in many different natural environments have been reported. Aquatic 
environments appear to support less diversity than soils and sediments. The number of 
microbial cells in terrestrial ecosystems has been estimated around 4–5 × 1030 microbial 
cells, while in water environments, such as oceans, the number of microbial cells is close 
to 1.2 × 1029 (1). Thus, microorganisms represent a highly diverse group and constitute 
about 60% of the Earth's biomass. Microorganisms are in the heart of all ecosystems and 
play critical roles in modulating global biogeochemical cycles and influence all lives on 
Earth (2,3). 
Beyond the studies reported for the elevated numbers and diversity of microorganisms, 
prokaryotes are recognized by their extremely diverse metabolic features, allowing them 
to adapt and inhabit in different environments. They have been described in habitats with 
normal conditions for their development, such as lake, rivers, soils, oceans and living 
organisms, but they  are also found in extreme environments where temperatures, pH, 
radiation, salinity, pressure and oxygen tension can be even too high or too low (4–6). 
Prokaryotes communities are extremely complex and structured entities characterized by 
their abundance, ubiquity and diversity, in which several members are key players in 
significant ecological processes as soil structure formation, decomposition of organic 
matter, recycling of essential elements and nutrients, regulation of atmosphere and 
photosynthesis (6,7). 
Aquatic ecosystems represent habitats for interrelated and interacting microbial 
communities and populations of plants and animals. The aquatic environment plays 
therefore vital roles for ecosystem functioning, human health and civilization. It is also 
known that anthropogenic activities can lead to the conception of the urban water cycle, 
affecting different sectors such as waste, surface and drinking water, where bacteria can 
be exchanged and mobilized between different aquatic habitats (wastewater, disinfected 
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water and drinking water), other environments and ultimately, can even reach humans. 
Freshwater habitats are one of the most natural habitats with a rich bacterial diversity (8). 
Hospital settings are characterized by multiplicity of different bacterial species, some of 
which may become resistant to antibacterial agents. This ecosystem remains complex, 
including not only the skin, gut and nasal flora of the patients, visitors and health 
professionals, as well as the environmental bacteria in everything from the water supply 
and drainage to bedside equipment and surfaces around. This means that one natural 
niche for a high diversity of microorganisms lies in the ecology of clinical settings. At the 
same time, this population of resistant commensal and environmental bacteria 
represents a reservoir for infections and dissemination of resistance, showing the ability 
to spread both human and natural environments (9–11). 
In recent years, increasing attention has been paid to the presence of emerging 
pollutants, active principles of drugs and their metabolites, chemicals, micropollutants 
and even pathogenic bacteria in the effluents of Wastewater Treatment Plant (WWTP) 
and in surfacewater. Despite the specific nature of hospital effluents, they are frequently 
discharged to public sewage networks, collected and co-treated with the urban effluents 
in the WWTP (12,13).  
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1.1 Hospital Environment 
Hospitals are colonized by a wide diversity of bacterial species and represent an excellent 
environment for the evolution and selection of antibiotic resistance. Although antibiotic 
resistance occurs due to the evolutionary natural selection, the misuse and overuse of 
antibiotics is dramatically increasing the selection of pathogenic bacteria resistant to 
multiple drugs. When these compounds are administrated wrongly in human or animal 
medicine, even for a short time, or small doses at inadequate strengths or for a wrong 
disease, bacteria are not killed and can acquire resistance genes and survive in the 
presence of these compounds, resulting in stronger infections and even death (14,15).  
Bacteria have the ability to develop or acquire a remarkable array of mechanisms that 
enable them to survive in the hospital surfaces and to overcome the effects of antibiotic 
compounds. This permanence in the hospital environment results in a serious problem: 
these strains can easily infect immunocompromised patients and the surrounding 
individuals, and therefore can be in the origin of nosocomial infections and in some cases 
can be a cause of nosocomial outbreaks. Consequently, the emergence of multidrug-
resistance (MDR) bacteria associated with infections is increasing, due to antibiotic 
selective pressure in the hospital environment (16). 
These health-care associated pathogens include norovirus, Clostridium difficile, 
methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci 
(VRE), Gram-negative bacilli as Acinetobacter baumannii and Pseudomonas aeruginosa 
(11,17). These nosocomial pathogens are responsible for causing Hospital-acquired 
infections (HAIs) and they have two unremarkable properties: they are recognized as 
hospital pathogens and they have an innate ability to survive colonize and persist on dry 
inanimate surfaces, such as bed rails, bedside tables, surfaces of ventilators, sinks, suction 
equipment, mattresses, resuscitation equipment, curtains, slings for patient lifting, mops, 
buckets, door handles, stethoscopes, incubators, computer keyboards, respiratory tract 
equipment and devices, for long periods of time (17,18). Therefore, contaminated 
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inanimate objects within the hospital environment can facilitate transmission of these 
nosocomial pathogens (19). 
Patients colonized or infected with nosocomial pathogens transmit and contact those 
microorganism onto their clothes, bed, skin and environmental surfaces around. The 
most susceptible individuals can acquire pathogens through direct contact with the 
equipment and surfaces, or even through hand contact of health professionals (11).  
 
Figure 1: The interplay of factors resulting in nosocomial infections (http://images.google.com) 
 
 
The overuse and misuse of antibiotics are important key points fueling this situation. The 
relationship between antibiotic use and emergence of resistance is complex (20). These 
clinical settings constitute the main places where antibiotics are used and applied in large 
scale. However, antibiotics compounds are chemically stable and can remain active in 
natural environments even for a few years, allowing these MDR strains to be widely 
spread in the environment (21–23). In addition, it has been reported that once antibiotics 
are administrated, the active substances of medicaments are metabolized, but only to 
some extent. The non-metabolized active substances are excreted by the patients in urine 
and in faeces, and enter into hospital effluents, which can be discharged into the urban 
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wastewaters without preliminary treatments, being co-treated with the urban 
wastewaters (13,14,24). 
 
1.1.1 Hospital Effluents 
Hospital wastewater (HWW) constitutes a major discharge of chemical residues and 
pharmaceuticals are found in all WWTP effluents, due to their inefficient removal by the 
conventional treatment processes (25).  Despite hospitals require a significant amount of 
water per day and for the different services, the quantity of wastewaters produced in a 
hospital depends on many factor: beds numbers, hospital age, water accessibility, general 
services inside the structure (laundry, kitchen), number and type of wards and units, 
institution management policies and others (Figure 2) (13). 
HWW is usually discharged directly without pre-treatment. Although the HWW represent 
only a small portion of the total wastewater volume in the influent of a WWTP, the public 
and scientific attention to HWW is increasing in the last decade (26). It is often assumed 
that hospitals are the most important source for input of antibiotics and resistant bacteria 
into municipal wastewater (27). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: HWW problems and their impact on WWTP and natural environments (adapted from Emmanuel, Perrodin, 
Keck, Blanchard, & Vermande, 2005) (12) 
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The common co-treatment of hospital and urban wastewaters at a municipal WWTP is 
not considered an appropriated practice, once it is grounded on dilution of different 
discharges and does not provide the separation of pollutants. Compared to urban 
wastewaters, HWW contain higher concentrations of pharmaceuticals, antibiotics, 
analgesics and bacteria. The concentrations of micropollutants in HWWs are between 4 
and 150 times higher than in urban wastewaters (13). 
The complications of removing micropollutants such as pharmaceuticals and bacteria 
from wastewaters are related to their concentration in the range of 10-3 - 10-6 mgL-1, 
which is much smaller than the concentrations of the conventional macropollutants. The 
removal of the micropollutants is depended of their behaviour and fate in the WWTP 
(solubility, volatility, biodegradability, polarity and stability) and the conventional 
treatments are not designed to be able to remove greatly microcontaminants (13,25). Some 
studies suggest that a pre-treatment of HWW prior to discharge into the sewers provides 
a reasonable solution and that this separate treatment may reduce the development of 
resistant bacteria, such as the amount of chemical and undesirable compounds (25–27). 
 
1.2 Aquatic Environments 
Water is one of the most important bacterial habitats on Earth, playing an important role 
for life and for human activities, reason why it represents an essential element for human 
existence.  Water for human consumption is often subjected to direct or indirect 
contamination by different ways of pollution including microbial agents from sewage or 
contaminants from other origins. Simultaneously, the concern related with the risks of 
the public supply of water is increasing and it requires a most rigorous quality control and 
a use of more sophisticated analytical capabilities in order to facilitate the detection and 
quantification of physical, chemical and microbiological agents that are potentially 
hazardous to health. For a long time that the presence of microorganisms from faecal 
materials in drinking or recreational water is recognized as a source of infectious diseases 
caused by bacteria, viruses or protozoa, representing a risk to human health (28,29). 
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Water is an ideal medium for bacterial life, affording access to readily accessible dissolved 
nutrients, as well as protection from desiccation and UV light (30). From all the microbial 
agents present in water, there are exogenous microorganisms (from faecal matters) and 
the indigenous microorganisms (which belong to the natural water microbiota).  Many of 
the pathogens associated to water can be also transmitted by food, which become more 
difficult to determinate the origin of some sporadic infections. Unless there is a failure in 
the water treatment process, normally an inadequate disinfection or a high intake of 
contaminated water, then the occurrence of pathogenic bacteria as Salmonella, Shigella, 
Vibrio and Campylobacter are rarely found. However, a wide range of opportunistic 
pathogens as Aeromonas, Pseudomonas and some species of Mycobacterium can be 
more commonly found (28,29). 
After being used, water returns to the environment in two possible forms, partially 
polluted or totally polluted which may compromise the quality of available water 
resources and increase the risk of waterborne diseases transmission. This pollution can 
occur due to the transport of toxic or chemical substances, organic materials and 
pathogenic microorganisms (28). 
 
 
1.2.1 Wastewater Treatment Plants 
The systems of water treatment are processes performed in untreated water in order to 
get a potable, chemical, bacteriological and biologically safe product for human 
consumption. For this, it is extremely necessary to remove and destroy any harmful 
organisms, harmful chemical substances as other materials either in suspension or 
solution. The type of water treatment differs with its origin (surface or underground) and 
its initial quality. Thus, the treatment of water for human consumptions means the 
production of healthy water that respects the chemical and microbiological safety 
requirements. The diversity of water treatments comprises clarification and 
sedimentation, filtration and disinfection (25,31). 
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Wastewaters can be designed as a recombination of liquid or water-carried waste 
removed from residences, institutions, and domestic, commercial and industrial 
establishments, in association with ground, surface and storm water. Its composition 
includes high load of oxygen demanding wastes, pathogenic agents, organic materials, 
some nutrients which stimulates plant growth, inorganic chemicals and minerals, 
sediments and sometimes toxic compounds (31). 
WWTPs are potential hot spots for horizontal transfer and selection of antimicrobial 
resistance genes among aquatic bacteria due the high microbial biomass and the richness 
of nutrients (32,33). Despite of representing a rich bacterial diversity and the high organic 
loads concentration that favor microbial growth, wastewater effluents suffer strong 
anthropogenic pressures as high levels of pollutant compounds (heavy metals, 
detergents, pesticides, antibiotics) (34).  
Conventional wastewater treatments consists of a combination of physical, chemical and 
biological processes and operation to remove solids, organic matter and sometimes 
nutrients of the wastewaters (31). 
Wastewater treatment can be differentiated as preliminary, primary, secondary and 
tertiary and/ or advanced wastewater treatment. 
i. Preliminary treatment consists in the removal of coarse solids and other large 
materials often found in raw wastewater, which helps to remove or to reduce in 
size the large, entrained, suspended or floating solids (pieces of wood, cloth, paper, 
plastics, garbage, together with some fecal matter). 
ii. Primary treatment consists in physical operations used to remove solids occurring in 
wastewater. 
iii. Secondary treatment intends to treat the effluent from primary treatment in order 
to remove most of organic matter and suspended solids with the use of biological 
and chemical processes. 
iv. Tertiary treatment intends additional processes and advanced biological methods, 
which are used to remove constituents namely, nitrogen or phosphorus that are not 
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reduced by the secondary treatment. It is defined as any process designed to 
produce an effluent of higher quality than that achieved by a secondary treatment. 
During the process of wastewater treatment, major qualitative and quantitative changes 
are observed in the distribution of the bacterial population (14,35). 
 
 
1.3 β-lactams Antibiotics 
Antibiotics are drugs used to treat bacterial infections that exert their action on bacteria 
by one of two basic ways. Some classes of antibiotics are classified as bacteriostatic, 
because they can act on the bacterial cell, inhibiting their growth or cell division; while 
others are bactericidal and may act on the bacterial cell leading to death (36). Some 
antibiotics have bacteriostatic activity in some circumstances while in other situations 
have bactericidal activity. Meanwhile, antibiotics can develop their action against a 
limited variety of bacterial species – narrow spectrum antibiotics; or can be efficient 
against a wide range of pathogens of different species – broad-spectrum antibiotics  (37). 
These compounds can be classified according to their chemical structure, action 
(therapeutic use) and spectrum of activity. Antibiotics of the same class have a similar 
toxicity and spectrum of activity (38). They can be natural or chemical products synthesized 
in laboratory and designed to selectively block essential processes in bacterial cells (eg, 
sulfonamides and quinolones) (39). 
The β-lactams antibiotics have been largely used as therapeutic agents since the second 
world war (40). The β-lactams antibiotics represent the group of antibacterial agents more 
diverse and used in the clinical treatment of infections caused by various bacteria, either 
in hospital or in the middle clinic (41,42).  
The β-lactam family is characterized by the presence of a β-lactam ring, cyclic structure of 
four atoms (one of carbon and three of nitrogen) with radical substituents.  The β-lactam 
ring is necessary for antibacterial activity, and the side chain determines the antibacterial 
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spectrum and pharmacologic properties. Depending on the structural characteristics of 
the side-chain β-lactams are classified into penicillins, cephalosporins, monobactams, 
carbapenems and inhibitors of β-lactamases (Table 1) (41,43).  A short description is given 
below: 
A. Penicillins and derivatives: reduced spectrum activity and susceptible to hydrolysis 
by the bacterial enzymes β-lactamases. The development of new molecules derived 
from the core compound of penicillin, 6-aminopenicillanic acid (6-APA), make it 
possible to obtain semi-synthetic penicillins (43). 
B. Cephalosporins: Semi-synthetic antibiotics grouped in first, second, third, and forth 
generation cephalosporins according to their spectrum of activity and to the timing 
of introduction in therapeutics (44). 
C. Carbapenems: considered as broad spectrum antibiotics. Imipenem and 
meropenem are well known representatives (41). 
D. Monobactams: The β-lactam is alone and not combined to another ring. Although 
they do not contain a nucleus with a fused ring attached, they belong to β-lactam 
antibiotics (45). 
E. β-lactam inhibitors: These compounds, like clavulanic acid, exhibit negligible 
antimicrobial activity and are usually combined with other β-lactams to combat 
strains that express β-lactamases (43). 
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Table 1: Classification of β-lactam antibiotics (adapted from Samaha-Kfoury & Araj, 2003; Suárez & Gudiol, 2009) 
 
β-lactams Groups Chemical structure Examples of β-lactam antibiotics 
Penicillins 
 Natural: Penicillin G, Penicillin 
Penicillinase resistant penicillins: methicillin, nafcillin, oxacillin, cloxacillin 
Aminopenicillins: ampicillin, amoxicillin 
Carboxypenicillins: carbenicillin, ticarcillin 
Ureidopenicillins: mezlocillin, piperacillin 
Cephalosporins 
 
First generation: cefazolin, cephalothin, cephalexin 
Second generation: cefuroxime, cefaclor, cefamandole, cefamycins 
(cefotetan, cefoxitin) 
Third generation: cefotaxime, ceftriaxone, cefpodoxime, ceftizoxime, 
cefoperazone, ceftazidime 
Fourth generation: cefepime, cefpirome 
Carbapenems 
 
Imipenem, meropenem, ertapenem 
Monobactams 
 
Aztreonam 
Inhibitors of β-
lactamases 
 
Tazobactam, Clavulanic Acid 
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1.3.1 Mode of Action of β-lactam Antibiotics 
Many of the antibiotics which act on the cell wall were discovered before the 
understanding of the biochemistry of cell wall biosynthesis (46). The cell wall is responsible 
for maintaining the bacterial shape and its integrity has a critical importance to cell 
viability. The cell wall provides an effective mechanical protection, which prevents the 
osmotic rupture of the cell in a hypotonic environment. It is composed by a dynamic 
structure that is continuously synthetized, modified and hydrolyzed in order to allow the 
cell growth and division (47,48). If the peptidoglycan synthesis is inhibited, it results in the 
death of a growing bacteria (49). 
Despite the differences related to the structure profile and the chemical composition of 
the cell wall of Gram-negative and Gram-positive bacteria, the scaffold of the cell wall 
consists of the cross-linked polymer called peptidoglycan (murein), a macromolecule 
which surrounds the bacterial cell and it is only found in prokaryotic cells. It is a molecule 
composed of amino acids and sugars, being constituted by parallel linear chains of two 
amino sugars, N-acetylglucosamine (NAG) and N-acetyl-muramic (NAM) disposed 
alternately and joined by β1-4 glycosidic linkages (48,50). 
Into each NAM molecule the peptide chains composed by modified amino acids are linked 
by amide bonds. The peptide chains of the surrounding linear chains establish among 
themselves inter-peptide bonds (crosslinking). This transpeptidation is the final step in 
peptidoglycan biosynthesis, and confers resistance to the bacterial cell wall, representing 
important natural target of β-lactam antibiotics, including penicillins and cephalosporins. 
The polymerization of the glycan strand (transglycosylation), and the cross-linking 
between glycan chains (transpeptidation) are catalyzed by the Penicillin-binding proteins 
(PBPs). These enzymes are transpeptidases or carboxypeptidases involved in 
peptidoglycan metabolism (51,52).  
While the peptidoglycan is being synthetized and during the reaction between two close 
chains, it must occur the acylation of a Ser residue present in the catalytic-site (active-
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site) of PBPs. Then, once the complex enzyme-D-Ala-D-Ala of a peptidoglycan molecule is 
created, the catalytic process is concluded through the ligation to a peptide chain of a 
second residue and this process allows the creation of the peptidoglycan structure (50,51). 
On the contrary, β-lactam antibiotics have slow activity as antibacterial, inhibiting the 
synthesis of cell wall and causing lysis of the bacteria (41). Firstly, they bind to the bacteria 
cell wall and then, they work by blocking the final stage of peptidoglycan synthesis 
through the inhibition of the enzymes involved in its formation (transpeptidases, 
carboxypeptidases). This mechanism is based on the binding of β-lactam antibiotics to the 
PBPs, preventing the synthesis of an intact cell wall. These antibiotics are only active 
against bacterial cells growing. The affinity of the antibiotic to PBPs is explained by the 
fact that the structure of the amide bond of the β-lactam ring is analogous to peptide 
bond of the D-alanyl-D-alanine (41,47).  
Figure 3 shows a schematic representation describing the cell wall formation synthesis, as 
well as the mechanism of action of β-lactam antibiotic. 
 
Figure 3: Cell wall formation and mechanism of action of β-lactam antibiotics (Cho, Uehara, & Bernhardt, 2014) 
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1.3.2 Resistance Mechanisms associated with β-lactam 
antibiotics 
Antibiotics reduce the bacterial grow or shut down essential cellular functions. Bacteria 
have the ability to develop different resistance strategies in order to adapt to the changes 
in their surroundings preventing antimicrobial agent from reach its target and acquire 
different mechanisms to render ineffective the antibiotics used against them (38,53). The 
antibacterial efficiency of a β-lactam antibiotic depends on the accessibility to its targets 
or the ability to diffuse through the cell membrane, the stability to bacterial hydrolytic 
enzymes (β-lactamases) and the affinity for the target enzymes (PBP’s) (54). 
Like it was mentioned before, the overuse/misuse of β-lactam antibiotics during the last 
years has largely contributed to the improvement, by bacteria, of several resistance 
mechanisms to these antibiotics. Four types of β-lactam resistance mechanisms are 
described as in Figure 4: (i) reduction of the permeability of outer membrane, (ii) 
alteration of the antibiotic target site (the PBPs), (iii) development of effective efflux 
systems and (iv) enzymatic degradation of the antibiotic mediated by β-lactamases. The 
hydrolysis of the β-lactam ring by beta-lactamases represents the most common and 
efficient resistance mechanism, subject that will be explored in section 1.4 (55). 
 
Figure 4: Major mechanisms of β-lactam resistance in both Gram-positive and Gram-negative bacteria (Tang et al., 
2014) 
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i.  Reduction of the permeability of outer membrane 
The cell wall of Gram-negative bacteria differs from the wall of Gram-positive bacteria, for 
instance by the presence of an outer membrane (55). This barrier performs a crucial role by 
offering protection from harmful compounds in the extracellular environment and by 
ensuring the entrance of nutrients and substances (antibiotics) to the bacterial cell 
through the presence of specific proteins responsible for the formation of channels 
known as porins (56).  
The diffusion of molecules and antibiotics is influenced by its charge, structure and size. 
Reductions in the cell permeability decrease the antibiotic flow and consequently its 
concentration in the periplasmatic space. Modifications in membrane permeability 
leading to the reduction of the antibiotic uptake across the outer membrane of Gram-
negative bacteria (57). One example of reduced cell permeability is related with strains of 
Pseudomonas aeruginosa, which have a reduced number of porins in the outer 
membrane and, therefore, they are intrinsically resistant to many antibiotics (56) .  
Besides the reduced number of porins, the changes in the cell permeability can occur as a 
result of porins loss due to mutation. Among the main porins described in Pseudomonas 
aeruginosa, OprD porin has a biological function in the passive uptake of basic amino 
acids across the outer membrane, but it also forms pores that are permeable to 
carbapenems, like imipenem is extremely effective against this bacteria through its 
diffusion by this porin (56,58). Another example is related to the largest and most abundant 
OprF porin, required for cell growth in low-osmolarity environment and for the 
maintenance of cell shape, and probably the most used by β-lactam antibiotics to 
penetrate within the bacteria (59). In Figure 5 are schematically represented some 
examples of antibiotic resistance mechanisms associated with porins.  
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Figure 5: Examples of different mechanisms of acquisition of mutational resistance associated with porins (adapted 
from Fernández & Hancock, 2012) 
 
 
ii. Alteration of the antibiotic target site 
One of the mechanisms whereby bacteria become resistant to antibiotics emerges 
through changing of the antibiotic target site, the PBPs. In most cases, these 
transpeptidases become less susceptible to binding with the antibiotic. Although this fact 
has been observed in Gram-negative bacteria, this resistance mechanism is particularly 
evident in Gram-positive bacteria. The changes in PBPs, including the expressions of PBPs 
with reduced affinity for β-lactam antibiotics or the decreased expression of specific PBPs, 
avoids the establishment of covalent bonds between β-lactam and PBPs conferring 
resistance to these compounds (60). 
The modification of these transpeptidases can be accomplished by one of the four 
mechanisms: acquisition of an additional low-affinity PBP; overexpression of an 
endogenous low-affinity PBP, increasing the level of resistance to β-lactam antibiotics; 
alteration of endogenous PBPs by point mutations, promoting the reduction of the 
affinity between PBP and the antibiotic or by homologous recombination or a 
combination of the above (52). 
Antibiotic Molecule 
Antibiotic cannot cross 
the outer membrane 
Outer membrane 
Periplasm Space 
Inner membrane 
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iii. Development of effective efflux systems 
In order to prevent the intracellular accumulation of antibiotics, bacteria have developed 
energy-dependent systems to pump such compounds out of the cell, providing an 
effective mechanism of resistance in some bacterial strains (61). Efflux pumps are normally 
proteins located in the cytoplasmic membrane, responsible for the extrusion of the 
antibiotic from cells into the external environment. These proteins are found in both 
Gram-positive and -negative bacteria (62). 
In Gram-positive bacteria, which lack the outer membrane, the cell wall does not offer 
much resistance to diffusion of small molecules and efflux pumps always include a single 
polypeptide located in the cytoplasmic membrane (61).  
However these efflux systems present a major complexity in Gram-negative bacteria due 
to the outer membrane, which acts as an additional protective barrier limiting the 
penetration of the antibiotic molecules. The antibiotic crosses the outer membrane and 
once the antibiotic reaches the cytoplasm, it can be picked up in the periplasm and 
directly expelled to the external medium. In this group of bacteria, resistance 
mechanisms appear often associated with changings in membrane permeability as the 
increased synthesis of constituent proteins of the efflux pump, due, for example, to 
mutations that occur in the repressor genes of these proteins. These mutations can also 
lead to the increased efficiency of the antibiotic transport to the outside of the cell. This 
mechanism can also appear associated with the production of β-lactamases (63,64). 
 
Figure 6:  Bacterial efflux pump (Tang, Apisarnthanarak & Hsu, 2014) 
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In Figure 6 is represented the effects of efflux pumps systems. In (i), it is described the 
extrusion of antibiotic molecules. In (ii), efflux pump inhibitor plug is blocking the outer 
membrane channel of the efflux system. In (iii), a non-antibiotic molecule or an efflux 
pump inhibitor is binding the site. In (iv) the antibiotic molecule is modified in order to 
avoid the extrusion by the efflux pump (60). 
 
(iv) Enzymatic degradation of the antibiotic mediated by β-lactamases 
The most common mechanism is the production of enzymes responsible for the 
degradation or modification of the antibiotic before it can reach the intended target, 
generating ineffective products. Therefore, the β-lactamase family degrades β-lactam 
antibiotics and are found widely in both Gram-negative and Gram-positive bacteria (42,65). 
These bacterial enzymes inactivate β-lactam antibiotics by hydrolytic cleavage of the β-
lactam ring, and their synthesis can be either chromosomal which can be inherent to the 
organism or plasmid mediated. As example, Pseudomonas aeruginosa possess 
chromosomal β-lactamase and often also acquires genes encoding β-lactamase which 
may be located in plasmids (42,66). 
The spread of β-lactamase genes has been largely accelerated by their combination with 
mobile genetic elements, as plasmids or integrons, allowing the transfer of genetic 
material to different bacteria. In Gram-positive bacteria, these hydrolytic enzymes are 
excreted as exoenzymes to the extracellular environment. In Gram-negative bacteria, β-
lactamases are secreted to the periplasm space and remain bounded to the cytoplasmic 
membrane, where they will degrade the β-lactam antibiotic before it can interact its 
receptor site (42,65). 
Given the diversity of enzymatic features of many β-lactamases, as their structure and 
substrates profiles described so far, many attempts were made to classify these enzymes 
(67). There two major approaches to categorize the β-lactamases family are represented in 
Table 2 and they are:  
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i. Molecular Classification: based in the molecular structure of the enzyme like the 
nucleotide and amino acid sequences, proposed by Ambler in 1980. The β-lactamases 
are divided into four molecular classes (A to D). Classes A, C and D are serine-
dependent enzymes that catalyze the hydrolysis of β-lactam antibiotics via a serine-
bound formed between the substrate and the active site serine. Class B or metallo-β-
lactamases are enzymes that require zinc for their β-lactam catalysis (49,65,68). As in the 
earlier functional classifications, enzymes were aligned based on their ability to 
hydrolyze specific β-lactam classes and on the inactivation properties of the β-
lactamase inhibitors clavulanic acid, sulbactam, and tazobactam. A description of each 
of the functional groups follows. 
ii. Functional Classification: focused in the functional and biochemical features, for 
example the antimicrobial substrate profile (their ability to hydrolyze specific β-lactam 
classes and enzyme inhibition profile (the inactivation properties of the β-lactamase 
inhibitors clavulanic acid, sulbactam, and tazobactam). According with this 
methodology, the first step is based on enzyme inhibition by EDTA chelating agent and 
the β-lactamases inhibited by this chelant are categorized in group 3 (metallo-β-
lactamases). After this evaluation focused in the enzyme inhibition, the enzymes are 
grouped according with the substrate profile. If the enzymes are able to hydrolyze 
benzylpenicillin and cephaloridine, they are considered as penicillinase or 
cephalosporinase, being included in group 1 and 2. The other subsets are defined due 
to their hydrolysis levels to other antibiotics. The inhibitors profile is also important, 
particularly for the β-lactamases that are not inhibited by clavulanic acid, which 
allowed the classification of these β-lactamases into group 4 (42,69). 
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Table 2: Groups proposed by the Bush classification and relationship with the Ambler classification (Adapted from 
Dhillon & Clark, 2011 and from Bush & Jacoby, 2010) 
 
Functional Group 
Molecular 
Class 
Common name β-Lactams to which resistance is conferred 
1 C Cephalosporinase Penicillins, cephalosporins 
2b A Penicillinase Penicillins, early cephalosporins 
2be A 
Extended-spectrum β-
lactamase 
Penicillins, extended-spectrum cephalosporins, 
monobactams 
2d D Cloxacillinase Penicillins, including oxacillin and cloxacillin 
2df D Carbapenemase Carbapenems and other β-Lactams 
2f A Carbapenemase All current β-Lactams 
3 D Metallo-β-lactamase All β-Lactams except monobactams 
4 - Penicillinase Penicillins 
 
 
 
 
1.4 Resistance Determinants approached in this study 
 
 
Resistance determinants can be inherited by vertical gene transfer (VGT), when they pass 
through generations as the cells divide as represented in Figure 7.  
 
 
Figure 7: Representation of the vertical gene transfer (http://images.google.com) 
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Resistance determinants can be also acquired by horizontal gene transfer (HGT), which 
involves the movement of genetic information between strains of bacterial species or 
genera (70).  The HGT is associated with mobile genetic elements (MGEs). HGT occurs 
through three different processes: via transformation (release of DNA by lysis and uptake 
by competent recipients), transduction (with the help of a bacterial virus) and conjugation 
(direct cell-to-cell contact for transfer of extra-chromosomal or chromosomal DNA) 
(Figure 8) (71). 
Antibiotic resistance genes (ARGs) are associated to MGEs like conjugative plasmids, 
transposons, insertion sequences (IS), integrons and bacteriophages, which can transport 
them in tandem (23,70). MGEs promote the movement of DNA within or between genomes, 
having a significant evolutionary impact and an important role in the dissemination of 
ARGs, once they allow the quick adaptation to the antibiotic’s classes in the environment 
and consequently, increasing the rate of MDR and their survival (38). HGT plays a critical 
role in the resistance dissemination and by the study of  the resistance determinants’ 
sources and the MGEs that spread them, it is possible to predict future threats and to try 
to control future recruitment and spread of ARGs (72). 
 
 
Figure 8: Mechanisms of horizontal gene transfer (Alekshun & Levy, 2007) 
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In this study, we focused our attention on blaTEM, blaSHV, blaCTX-M, blaVIM and class 1 
integron integrase (Int1) genes. 
 
1.4.1 Extended-spectrum β-lactamase (ESBL) 
 
The first extended-spectrum β-lactamase (ESBL) was identified in an isolated 
Enterobacteriaceae in Germany in 1983, after the introduction of broad spectrum 
cephalosporins. Since then, the incidence of ESBLs has been increasing worldwide, being 
mostly described in Escherichia coli and Klebsiella (73,74). There is no consensus of the 
exact designation of ESBL and a general definition consists of several elements (75,76).  
Bacteria producers of ESBL has an important role in the global spread of resistance in 
hospital environments. Many factors as the increased period of hospital permanence, 
insertion of catheters, execution of invasive procedures, chirurgic interventions or 
implementation of renal replacement therapies have been widely associated to the 
isolation of bacteria producers of ESBL in hospitalized patients (77,78). 
 
 
Figure 9: Recent evolution of pandemics caused by bacteria that produce β-lactamases, especially extended-spectrum 
β-lactamases (ESBL) (Pitout, 2010) (78) 
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These enzymes are classified in class A and D (Ambler classification) or in the subgroup 
2be or 2d (functional classification). Their expression is associated with bacterial 
resistance to penicillins, first-, second-, and third-generation cephalosporins and are 
inhibited by β-lactamase inhibitors as clavulanic acid (79). There are various genotypes of 
ESBL and they are classified in different ways according to their amino-acid sequence and 
to their hydrolytic profile. The most common are SHV, TEM and CTX-M (66,80). Most of 
ESBL derived from simple point mutations (substitution of a single amino acid) in the 
active site of the classical β-lactamases TEM-1, TEM-2 and SHV (75). So far, there are 
several variants of TEM and SHV types, although not all of them have ESBL phenotype. 
Unlike TEM/SHV enzymes, all the CTX-M enzymes are ESBLs (81). 
i. TEM β-lactamases:  The first β-lactamase identified, plasmid-mediated in gram-
negative, was TEM-1 and it was discovered in Greece in 1960 from an E. coli 
isolated from a patient called Temoniera, giving the designation of TEM β-
lactamase (80). TEM-1 is capable to hydrolyze penicillins and early cephalosporins 
(cephalothin and cephaloridine) (80,82).  The amino acid substitutions in TEM-1 
occur in a limited number of positions. Combinations of these substitutions result 
in various phenotypes of ESBLs as the ability to hydrolyze cephalosporins such as 
ceftazidime and cefotaxime (80). The number and position of the amino acid 
replacements are very important for the ESBL phenotype production. The 
substitutions of glutamate by lysine in position 104, arginine by histidine or serine 
at position 164, glycine by serine at position 238 and glutamate by lysine at 
position 240 are the most important (80). Although the β-lactamases TEM type are 
frequently found in Escherichia coli and Klebsiella pneumoniae, they also have 
been reported in many different species for example of the family 
Enterobacteriaceae, Pseudomonas aeruginosa, Haemophilus influenzae and 
Neisseria gonorrhoeae  (76,80). 
ii. SHV β-lactamase: Meanwhile, another β-lactamase, known as SHV-1 (because 
sulfhydryl reagents had a variable effect on substrate specificity) and sharing 68% 
similarity in terms of amino acid sequence with TEM-1, was found in Klebsiella 
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pneumoniae, E. coli and wide range of Enterobacteriaceae (79). The SHV-1 β-lactamase 
is chromosomally encoded in the majority of isolates of K. pneumoniae, but it is 
usually plasmid mediated in E. coli (80,82,83).  Most SHV are characterized by 
substitution of a glycine for serine at position 238.  The changes that have been 
observed in blaSHV to give SHV variants occur in less different positions (80). SHV-1 
confers resistance to broad-spectrum penicillins as ampicillin, tigecycline and 
piperacillin but not to the oxyimino substituted cephalosporins (82). 
iii. CTX-M β-lactamase: CTX-M β-lactamases represent a new family that specially 
hydrolyzes cefotaxime and that have emerged and spread during recent years. It 
has been frequently been detected in isolates of E. coli, Salmonella enterica 
serovar Typhimurium and other species of Enterobacteriaceae. The CTX-M β-
lactamases are encoded by genes that have been captured by mobile elements 
from the chromosome of the environmental bacteria Kluyvera spp. (73,80). This 
family has been first described in Germany and Argentina, and they are not very 
closely related to TEM or SHV β-lactamases, showing only 40% of identity with 
these β-lactamases (78,80). Another feature that characterizes these enzymes is 
related with the fact that they are better inhibited by the β-lactamase inhibitor 
Tazobactam than by sulfabactam and clavunate. It includes five different groups of 
enzymes (CTXM-1, CTX-M-2, CTX-M-8, CTX-M-9, and CTX-M-25) (76,78,80,84). So far, 
there are more than 200 CTX-M variants (85). 
 
1.4.2 Metallo-β-lactamases 
 
In the mid-1960s MBL were firstly detected in species with low pathogenic potential. 
Since the 1990s, several of these enzymes encoded by mobile DNA elements have 
emerged in important Gram-negative pathogenic bacteria as Enterobacteriaceae, 
Pseudomonas aeruginosa, and Acinetobacter baumannii, increasing their clinical 
relevance (86). MBL belong to class B of the structural classification of β-lactamases (67). 
They are considered metallo-enzymes since they require the presence of one or two zinc 
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cations in the active site and are inhibited by the chelating agent EDTA. These enzymes 
usually can confer resistance to some penicillins, cephalosporins and carbapenems, but 
not to monobactams (86,87). 
The most important types for epidemiological dissemination and clinical relevance are the 
IMP-type, VIM-type, SPM-type, and NDM-type enzymes. The VIM-type enzymes 
(Veronese imipenemase) were discovered in Europe in 1990s and more than 20 VIM 
allotypes are described. These enzymes are known by their high affinity for carbapenems. 
VIM-1 was reported in Pseudomonas aeruginosa in Verona, Italy, followed by VIM-2 
reported in Greece and France (86,88). blaVIM gene is horizontally movable because it is 
normally inserted in integrons and some of them are located in conjugative plasmids 
(86,89). 
1.4.3 Class 1 integron integrase gene  
 
Integrons are DNA elements that can be transferred from one organism to another, but 
they cannot move by themselves. They have the ability to capture genes that confer 
antibiotic resistance by site-specific recombination mechanism, instead of transposition 
(23,90).  They are gene expression elements capable of incorporate open reading frames 
(ORFs) and convert them to functional genes. These ORFs are contained in modular 
structures known as gene cassette which are the smallest genetic entities that can carry 
resistance determinants. Genes cassettes are not necessarily part of the integron, but 
they become part of the integron when they are integrated (91,92).  
 
i. Integron structure and transferability 
These DNA elements are characterized  by two conserved segments (CS) flaking a central 
region known as variable region (VR) in which the gene cassette can be inserted (92,93). 
They are composed of three keys elements necessary for to integrate and express 
exogenous genes: a gene encoding for an integrase (intI), a primary recombination site 
(attI) and  a strong promoter that will promote the expression of any suitable integrated 
gene (91,94).  
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The integrase encoded by intI gene belong to a tyrosine recombinase family, which 
includes proteins that recombine DNA duplexes by performing two successive strand 
breakage and rejoining steps and a topoisomerization of the reactants. The integron 
integrase catalyze the insertion and excision of gene cassettes by specific-site 
recombination. Recombination takes place between two recombination sites, attI and 
attC.  The integrase mediates recombination first between the attI site, located in the 5’-
CS of the integron platform, downstream the intI gene where the incorporation of gene 
cassettes occurs, and a secondary target called an attC site. The attC x attI 
rearrangements catalyzed by integrase lead preferentially to cassette integration at attI 
site, allowing gene cassette expression. attC x attI recombination mediated by integrase 
may also occur, resulting in gene cassette deletion through circular intermediate (95–97). 
 
 
Figure 10: Mechanism of integron-mediated gene capture. Integrase catalyzes the insertion of circular gene cassettes at 
the attI site through site-specific recombination (Cambray, Guerout, & Mazel, 2010) (97) 
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ii. Class 1 integrons 
The class 1 integrons are frequently associated with plasmids or transposons, containing 
few gene cassettes that encode antibiotic resistance determinants, or can be located on 
the bacterial chromosome, in which case can contain several hundreds of cassettes 
encoding unknown functions (97,98). These integrons have been distributed in clinical 
organisms (99,100). 
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2. Objectives 
 
The following study was conducted in order to clarify the following aspects: 
 Are there resistance genes in hospital effluents? Do these antibiotic resistant 
genes reach the municipal networks? Do they reach the environment after the 
wastewater treatment? 
 What are the detectable differences between the structure of microbial 
communities from the hospital wastewaters and from the wastewaters from the 
treatment plant? 
 In the WWTP, is there differences in the microbial communities before and after 
the treatment? Is there any change in the abundance of ARGs before and after the 
treatment? 
To achieve this, the following approaches were employed/used: 
i. To evaluate the presence of ARGs, such as blaCTX-M, blaVIM, blaSHV, blaTEM and intl1 
in bacterial communities inhabiting wastewaters with different origins; 
ii. To perform the absolute quantification by quantitative PCR (qPCR) of the same 
ARGs mentioned before; 
iii. To evaluate the composition and bacterial diversity of communities between the 
different samples from the Hospital Aveiro and WWTP Aveiro effluents, collected 
in two distinct seasons, summer and winter. 
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3. Material and Methods 
 
3.1 Site description 
The Centro Hospitalar of Baixo Vouga, E.P.E. – Aveiro represents an institution which goal 
is to provide the quality health care to a population of about 300000 inhabitants, spread 
over nine municipalities of Aveiro District. With 1500 employees, the hospital provides 
support in clinical services, 400 beds of hospitalization and two Emergency Services open 
24 hours: the one from Aveiro (Medical-surgical emergency) and the other of Águeda 
(basic urgency). However, the clinical placement of this study was related with the 
facilities in Aveiro, more specifically the effluents of hospitalizations wards and of 
microbiology laboratory (101). 
The WWTP of Cacia, located in Cacia (Aveiro), was designed to satisfy the treatment 
needs of effluents from Águeda, Aveiro, Albergaria-a-Velha, Estarreja, Murtosa, Oliveira 
do Bairro, Ovar and Santa Maria da Feira. This WWTP is part of Saneamento Integrado 
dos Municípios da Ria de Aveiro (SIMRIA), which is responsible for the construction, 
management and exploration of Sistema Multimunicipal de Saneamento da Ria de Aveiro. 
The main goal of SIMRIA is related with the satisfaction of collection needs, treatment 
and rejection of domestic and industrial wastewater effluents from the municipalities 
mentioned above (http://www.adra.pt/). This WWTP execute a biological treatment of 
secondary level using activated sludge (102).  
 
3.2 Sample Collection 
 
Water samples were collected from two effluents of Centro Hospitalar do Baixo Vouga – 
Aveiro, representing the wastewaters of hospitalizations and Medicine I ward and of the 
microbiology laboratory, and from two effluents of the WWPT of Cacia – Aveiro, which 
include the wastewaters of the pre-treatment and post-secondary treatment effluents, 
respectively.  
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Water samples from hospital effluents were collected at 20th November 2014 and 29th 
June 2015. Due to the discontinuous nature of the wastewaters from the hospital wards 
(Medicine I) and of microbiology laboratory, a composite sampling method was adopted 
and the samples were collected three times throughout the sampling day (morning, noon, 
and evening) and then mixed together in order to have a representative sampling of 
these services. Water sampling of WWTP was performed in a single collection at 27th 
November 2014 and 29h June 2015. Samples were collected in 1L autoclaved bottles and 
kept at 4 ᵒC until DNA extraction.  
The following flowchart shows a schematic representation of the samples collection 
(Figure 11).  
 
 
 
 
Figure 11: Flowchart with the sites and samples description. 
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3.3 DNA Extraction 
Water samples (50 to 100mL) were pre-filtered through 5µm pore-size polycarbonate 
sterile filters to eliminate small eukaryotes and suspended particles and then bacterial 
cells were collected on 0.2 µm size filters. Cells were immediately washed from the filters 
using 2mL of TE buffer (10mM Tris-HCL, 1mM EDTA, pH 8.0) and suspended particles 
were harvested by centrifugation (16,000g for 15min). The pellet was resuspended in 
100µL TE buffer containing 10mg/mL of lysozyme and incubated for 1h at 37 ᵒC to 
improve cell lysis.  After the described lysis steps, the extraction of DNA was performed 
with the Genomic DNA Purification Kit (MBI Fermentas, Vilnius, Lithuania), according to 
the manufacture’s instruction (Appendix 1). Aliquots were loaded onto 0.8% agarose gels 
and separated by electrophoresis at 100 V for 50 min. 
In order to remove all the RNA present, 5 µL of 10mg/mL DNase-free RNase A (Roche) 
was added, followed by an incubation at 37 ᵒC during 1h. DNA purification was performed 
by Phenol-Chloroform-Isoamyl Alcohol (phenol/CIA) treatment. Deproteinization was 
performed by adding 1 volume of phenol/CIA, followed by centrifugation of 5 min at 
14000 x g. The upper aqueous phase was transferred to a clean and sterile microtube. 1 
volume of CIA was added and the upper aqueous phase was transferred to a new sterile 
microtube. Briefly, 1/10 volumes of a 0.5 M sodium acetate solution (pH 5.2) and 2.5 
volumes of cold ethanol (-20 ᵒC) were added to the aqueous phase obtained from the 
phenol/CIA extraction. The solution chilled at – 70 ᵒC for 1h. After centrifugation for 30 
min in a refrigerate centrifuge (4 ᵒC) at maximum speed, the ethanol was removed and 
the pellet washed with 300 µL of 70 % ethanol. This solution was removed by 
centrifugation during 5 min at 13000 rpm and the pellet was dried, and resuspended in 
100 μL of TE buffer. Samples were stored at -20 ᵒC. Aliquots were loaded onto 0.8% 
agarose gels and separated by electrophoresis at 100 V for 50 min. 
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3.4 Amplification of the 16S rRNA gene 
16S ribosomal RNA gene (rRNA) amplicon analysis remains the standard approach for the 
cultivation-independent analysis of microbial diversity and for the DNA quality of the 
template. Samples dilutions were performed to observe the possible presence of 
inhibitors. The dilutions of the samples, reduce the template concentration, which 
automatically result in a dilution of the PCR inhibitors. 
The general bacterial primers fD1 (5’-AGAGTTTGATCCTGGCTCAG–3’) and rD1 (5–
AAGGAGGTGATCCAGCC–3’) corresponding to positions 8–27 and 1522–1538 on 
Escherichia coli 16S rRNA gene, were used to amplify nearly full-length 16S rRNA genes 
(103). Each reaction was performed in a final volume of 25 μL containing 50 -100 ng of 
purified DNA and a mix with 3 mM MgCl2, 1X PCR buffer (PCR buffer without MgCl2:PCR 
buffer with (NH4)2SO4, 1:1), 5% DMSO, 0.2 mM dNTPs, 0.3 pmol/μL of each primer and 
Taq polymerase NZYTech (0.02U/ μL). The temperature profiles were as follows: initial 
denaturation (94 ᵒC for 9 min); 30 cycles of denaturation (94 ᵒC for 30 s), annealing (56 ᵒC 
for 30 s) and extension (72 ᵒC for 90 s); and final extension (72 ᵒC for 10 min). The 
reactions were carried out in a Bio-Rad C1000TM Thermal Cycler (Bio-Rad Laboratories, 
Hercules, California, USA). PCR products were separated by electrophoresis in a 1% 
agarose gel at 100 V for 50 min. 
 
3.5 Denaturing Gradient Gel Electrophoresis (DGGE) 
DGGE is a fingerprinting method which provides insights into the structure and dynamics 
of microbial communities, being commonly used in the analysis of bacterial diversity and 
community structure in water samples. As a pioneer group, Muyzer and his co-workers 
analyzed bacterial communities of marine sediments and biofilms isolated from 
wastewater treatment reactors (3,104). One of the biggest advantages is related with its 
reproducibility and ability to compare multiple samples simultaneously on the same gel 
(105). 
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This molecular approach allows the separation of small amplicons normally up to 400pb, 
which is achieved according to their different guanine and cytosine content and 
distribution. Before performing electrophoresis, the PCR products are obtained from 
environmental DNA using primers for a specific molecular marker (16S rRNA gene), with a 
5’-GC clamp (30-50 nucleotides) in the forward primer, which is crucial to prevent the two 
DNA strands to complete dissociate into single strands. Therefore, the fingerprint pattern 
is created according to the melting features of the sequences along a linear denaturing 
gradient, which is obtained by using denaturing chemicals. In this analysis, each band 
corresponds to a distinct taxonomic group, resulting in a profile that can be compared. It 
is assumed that the variations between the intensities of bands in the DGGE gel reflect 
the relative abundance of different phylotypes in the bacterial communities (3,105). 
DGGE was performed to analyse the following samples, I, II, III and IV.  The V3 region of 
bacterial 16S rRNA was amplified using the primers 338F (5’-
GACTCCTACGGGAGGCAGCAG-3’) and 518R (5’-ATTACCGCCGCTGCTGG-3’) with a GC 
clamp attached to the forward primer (104). PCR was performed in 50 µL reaction mixtures 
containing 1X PCR buffer (PCR buffer without MgCl2:PCR buffer with (NH4)2SO4, 1:1), 3 
mM MgCl2, 5% DMSO, 200 µM each nucleotide, 0.3 pmol/μL of each primer and Taq 
polymerase NZYTech (5U/ μ). Negative controls without template DNA were run for the 
primer set to ensure absence of contaminating template DNA.  
The temperature profile was as follows: initial denaturation (95 ᵒC for 5 min); 30 cycles of 
denaturation (95 ᵒC for 30 s), annealing (55 ᵒC for 30 s), and extension (72 ᵒC for 30 s); 
and a final extension (72 ᵒC for 30 min). The reactions were carried out in a Bio-Rad 
C1000TM Thermal Cycler (Bio-Rad Laboratories, Hercules, California, USA). 
DGGE was performed on a DCodeTM Universal Mutation Detection System (Bio-Rad, USA). 
Samples containing approximately equal amounts of PCR amplicons were loaded onto 8% 
polyacrylamide gels (37.5:1, acrylamide/bisacrylamide) using a denaturing gradient 
ranging from 37% to 65% (100% denaturant is 7 M electrophoresis-grade urea (Sigma- 
Aldrich, Germany), 40% v/v formamide (Sigma-Aldrich, Germany)).  Electrophoresis was 
performed at 60 ᵒC in 1x TAE buffer, at 20 V cm-1  for the first 15 min and then at 75V cm-1  
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for 16h. After electrophoresis, the gels were stained for 5 min with ethidium bromide (0.5 
mg L-1) and then rinsed in dH2O for 20 min. The image was acquired using a DGel DocTM 
XR+ (Bio-Rad Laboratories, Hercules, California, USA). 
The DGGE banding patterns were analyzed with GelCompar II version 6.1 software 
(Applied Maths, USA). Similarities between the banding patterns were studied using the 
Pearson correlation coefficient based on the relative intensity of each band. Similarities 
were displayed graphically as a dendrogram. The clustering algorithms used to calculate 
the dendrograms was an unweighted pair-group method with arithmetic averages 
(UPGMA). 
 
3.6 Screening for Antibiotic Resistance Genes by PCR 
The PCR reactions were performed in a final volume of 25 μL containing 50 -100 ng of 
purified DNA and a mix with 3 mM MgCl2,  1X PCR buffer (PCR buffer without MgCl2:PCR 
buffer with (NH4)2SO4, 1:1), 5% DMSO, 0.2 mM dNTPs, 0.3 pmol/μL of each primer and 
Taq polymerase NZYTech (0.02U/ μL).  The reactions were carried out in a Bio-Rad 
C1000TM Thermal Cycler (Bio-Rad Laboratories, Hercules, California, USA). 
blaCTX-M, blaSHV, blaTEM, blaVIM and intI1 genes were amplified with specific primers. The 
sets of primers used, references, annealing temperatures and predicted amplicons sizes 
are shown in Table 3. The temperature profile was as follows: initial denaturation (94 ᵒC 
for 4 min); 30 cycles of denaturation (94 ᵒC for 30 s), annealing (as indicated in Table 3) 
for 30 s, and extension (72 ᵒC for 45 s); and a final extension (72 ᵒC for 5 min).  
PCR products were separated by electrophoresis in a 1.5% agarose gel at 100 V for 50 
min. 
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Table 3: Primers used in this study 
Target 
Primer 
Pair 
Primer Sequence (5’–3’) 
Annealing 
(ᵒC) 
Amplicon 
Size (bp) 
Reference 
blaCTX-M 
CTX.M_F ACCAACGATATCGCGGTGAT 
62 101 
Colomer-Lluch, Jofre, 
& Muniesa, 2011(106) 
CTX-M_R ACATCGCGACGGCTTTCT 
blaTEM 
TEM_F CATTTTCGTGTCGCCCTTA 
59 167 Yang et al., 2012(107) 
TEM_R GGGCGAAAACTCTCAAGGAT 
blaSHV 
SHV_F GCGAAAGCCAGCTGTCGGGC 
64 304 Jiang et al., 2013(108) 
SHV_R GATTGGCGGCGCTGTTATCGC 
blaVIM 
VIM_F TCCGACTTTACCAGATTGCC 
57 159 Falcone et al., 2009(109) 
VIM_R CGAGAAGTGCCGCTGTGTTT 
intl1 
IntI_F GCCTTGATGTTACCCGAGAG 
62 196 
Barraud, Baclet, Denis, 
& Ploy, 2010(98) 
IntI_R GATCGGTCGAATGCGTGT 
 
 
 
 
In Table 4 are described bacterial strains used as controls in this study, some relevant 
characteristics, their origin and references.  
 
Table 4: Bacterial strains used in this study 
Strain Genes Characteristics References 
E. coli 537 blaCTX-M 
Escherichia coli  collected 
from patients during a 
control study 
Unpublished 
E. coli A7 blaSHV, blaTEM 
Escherichia coli isolated 
from seawater 
Alves et al., 2014(110) 
Klebsiella pneumoniae Kp1 intl1 Escherichia coli  collected 
from an inanimate surface  
Santos, Caetano, 
Ferreira, Ramalheira, & 
Mendo, 2011(1 11) 
Pseudomonas P1 blaVIM 
Pseudomonas collected 
from patients during a 
control study 
Unpublished 
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3.7 Quantification of Antibiotic Resistance Gene by 
quantitative PCR 
Quantitative PCR is a highly sensitive technique which basic goal is to distinguish and 
measure specific nucleic acid sequence in samples even if there is only a small quantity. 
The amount of DNA is measured after each cycle via fluorescent dyes that yield increasing 
fluorescent signal in direct proportion to the number of PCR product molecules 
(amplicons) generated, which is in contrast with end-point detection of amplified genes in 
conventional PCR, once it does not enable accurate quantification of nucleic acids (3). 
qPCR has been used successfully in environmental samples for quantitative detection of 
important physiological groups of bacteria and for quantification of antibiotic resistance 
genes, representing an important culture-independent tool for the identification of ARGs 
and for the measurement of the abundance and expression of taxonomic and functional 
gene markers in aquatic environments (112). 
To quantify the number of ARGs we analyzed the total DNA from wastewater and hospital 
effluent samples using quantitative PCR (qPCR) through absolute quantification. Absolute 
quantification is based in a standard curve generated from the amplification of known 
concentrations of the target genes (standards) in order to measure the true copy number 
of a particular gene (113). 
 
3.7.1 Preparation of Standard Curves 
For the generation of the standard curves, a plasmid construction was used. The 
fragments of the ARGs were amplified by conventional PCR with the specific primers for 
qPCR as described previously in Table 3. 
The PCR reactions were performed in a final volume of 25 μL containing 50 -100 ng of 
purified DNA and a mix with 3 mM MgCl2,  1X PCR buffer (PCR buffer without MgCl2:PCR 
buffer with (NH4)2SO4, 1:1), 5% DMSO, 0.2 mM dNTPs, 0.3 pmol/μL of each primer and 
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Taq polymerase NZYTech (0.02U/ μL).  The temperature profile was as follows: initial 
denaturation (94 ᵒC for 4 min); 30 cycles of denaturation (94 ᵒC for 30 s), annealing (as 
indicated in Table 3 for 30 s), and extension (72 ᵒC for 45 s); and a final extension (72 ᵒC 
for 5 min). PCR products were separated and confirmed by electrophoresis in a 1% 
agarose gel at 100 V for 50 min. Afterwards, PCR products were purified with the 
NZYGelpure (NZYtech) as described in Appendix 3. 
These PCR products were ligated into the pNZY28-A plasmid vector through the NZY-A 
PCR Cloning Kit (NZYtech) according to the manufacturer’s instructions. Ligations were 
carried out in a total volume of 10μL containing 1µL of pNZY28-A plasmid vector (50 
ng/µL), 1µL of the fresh purified PCR product (50 ng/µL), 5 µL of NZY-A ligase buffer (10X) 
and 1 µL of T4 DNA Ligase (2U/µL). The mixture was incubated overnight at 4 ᵒC and after 
it, conserved at -20 ᵒC until further use. Approximately 10 μL of this reaction was used to 
transform chemically competent E. coli DH5α cells (Appendix 4). Positive clones were 
selected based on ampicillin resistance and white/blue selection by incubation on LB agar 
plates containing 100 μg/mL of ampicillin, 100 μg/mL of X-Gal and 0.5 mM of IPTG 
(Appendix 4).  
Mini-preparations were used for plasmid DNA extraction from the positive clones and 
were performed with NZYMiniprep NZYtech kit as explained in Appendix 5. Plasmids 
harboring the inserts were linearized by digestion with the EcoRI endonuclease. The 
digestion reaction was performed in a total volume of 20 µL containing 5 µL of the 
resulting plasmid DNA, 1 µL of EcoRI (10 U/µL), 2µL of Buffer EcoRI (10X) and 12 µL of 
nuclease-free water, followed by two incubations: the first one of 37 ᵒC during 1h 
(digestion reaction) and the second one of 65 ᵒC during 20 min (enzyme inactivation). 
Each digestion was loaded on a 1% agarose gel and electrophoresis was performed at 
120V during 30 min.  
At the same time and in order to confirm the presence of the intended DNA fragments in 
the respective plasmids, a PCR was performed using the universal primers T7prom (5’- 
AATACGACTCACTATAGGGAGACCAC-3’) and M13 Reverse (5’-CAGGAAACAGCTATGAC-3’). 
Each reaction was performed in a final volume of 25 μL containing 3 mM MgCl2, 0.22 mM 
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dNTPs, 1X PCR buffer (PCR buffer without MgCl2:PCR buffer with (NH4)2SO4, 1:1), 0.3 
pmol/μL of each primer. Taq polymerase NZYTech (0.02U/μL) and 1 μL of each intended 
plasmid DNA. The amplification parameters were as follows: 94 ᵒC for 4 min, 35 cycles of 
94 ᵒC for 30 sec, 45 ᵒC for 30 sec and 72 ᵒC for 45 sec and a final extension step of 5 min 
at 72 ᵒC. The presence of the correct amplicons was evaluated on 1.5 % agarose gel 
electrophoresis.  These plasmid DNA containing blaCTX-M, blaSHV, blaTEM, blaVIM and intI1 
genes were stored at -20 ᵒC until further utilization. 
The plasmid DNA concentration was determined by Qubit (Invitrogen) according to 
manufacturer’s instructions (Appendix 6). Copy number of each ARGs per microliter of 
plasmid solution was calculated by the expression: 
Copy Number of ARG/µL= (L × C) ⁄ (N × M×109 ) 
According with this expression, L is Avogadro’s constant (6.02 × 1023/ mol), C is the mass 
concentration of plasmid in nanogram per microliter, N is the length of template 
containing the ARG (Table 3) and pNZY28-A plasmid vector (2886 bps), and M is the 
molecular weight of an average base pair of DNA (660 g/mol) (114). 
Five point standard curves for qPCR were generated using ten-fold serial dilutions of the 
plasmid carrying target genes, from 107 to 102 copy numbers.  Standard curves were 
generated using known quantities of cloned target genes. These ten-fold serial dilutions 
of plasmid DNA were amplified in triplicate to establish the standard curve for each qPCR 
assay. Each standard was generated by a correlation coefficient (R2) of the plotted points.  
 
3.7.2 Quantification of ARGs 
qPCR reactions were conducted in 96-well plates with a final volume of 20 µL containing 
10 µL of SsoFast™ EvaGreen® Supermix (Biorad, USA), 1 µl of DNA and 25 nM primers. 
The SoFastTM EvaGreen® Supermix was used according to manufacturer’s instructions. 
Specific primers were designed based on the sequence of the genes to be analyzed. 
- 41 - 
 
 
 
Primers used in each qPCR assay and the respective reference, annealing temperatures 
and predicted amplicon sizes are given in Table 3.   
The Thermal cycling and fluorescence detection were performed using the CFX96™ Real-
Time System (Biorad, USA, coupled with the C1000TM Thermal Cycler (Bio-Rad). Briefly, 
an initial setup of 30 s at 95 ᵒC was followed by 40 cycles of 10 s of denaturation at 95 ᵒC 
and 15 s of annealing/extension at the temperature described in Table 3 according to 
each primer. Melting curves were performed to identify the presence of primer dimers 
and to analyse the specificity of the reaction. The negative control was the reaction mix 
with nuclease-free water instead of template DNA analysis. 
All negative controls resulted with no amplification or a higher threshold cycle (Ct) than 
the most diluted quantification standard (102 copy number). A sample was considered to 
be below the limit of detection (LOD) for a target gene if ≥2 out of 3 replicates were 
negative or if sample Ct values were ≥Ct of negative controls. Samples above LOD were 
considered to be below the limit of quantification when the standard deviation (s.d.) of Ct 
values of methodological triplicates was >0.5 and their Ct value was higher than the Ct of 
the most diluted standard whose standard deviation of Ct values was ≤0.5 (115). 
In order to evaluate the presence of inhibitors, each of the samples was spiked with 105 
copies of quantification standard DNA and amplified together with the same set of non-
spiked samples and control DNA. The experimental difference was compared to the true 
copies of target genes in the standards. The presence of inhibitors was evaluated 
according to Pei et al. (2006) by calculating the suppression factor (115,116). Suppression 
factor was calculated according to the following formula:  
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All qPCR products were electrophoresed on 1.5% agarose gel in order to confirm the 
presence of a single band with the expected size. The concentrations of gene copy 
number were presented in gene copy number per milliliter of sample. 
 
3.8 Statistical Analysis 
 
Regarding to comparisons of genes abundance among the different sampling points. The 
statistical analysis was performed using one-way ANOVAs and Kruskal-Wallis one-way 
analysis of variance on ranks, whenever the data failed to meet the normality and 
homoscedascity assumptions.  Differences were considered significant at p <0.05. All 
statistical analyses were performed using SigmaPlot 11.0 software. 
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4. Results and Discussion 
4.1 DGGE analysis of bacterial community structure 
 
 
DGGE analysis of 16S rRNA gene PCR products was used to investigate bacterial 
community structure in hospital wastewaters and in urban effluents from the WWTP of 
Cacia. The DGGE profiles obtained are shown in Figure 12. 
 
Figure 12: DGGE gel showing PCR-amplified bacterial 16S rRNA gene fragments for 8 samples (indicated on the top of 
each lane) collected in November 2014 and June 2015. M: Marker I (Wako, Japan); I: Hospital-medicine effluent; II:  
Hospital-microbiology laboratory; III: Pre-treament effluent from WWTP; IV: Post-treament effluent from the WWTP; C-
: Negative control of the each amplification; X :lanes not considered. 
 
M
nk 
C- x 
 
M C- M I II III IV x I II III IV 
Collected in November Collected in June 
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Based on DGGE banding profiles (Figure 12), a dendrogram was constructed (Figure 13). 
To establish relationships between samples, the densitometric curves were compared by 
using Pearson correlation coefficient. The cluster analysis was performed to gain an 
overview on the relatedness of profiles representing the communities of each site and of 
each sampling date. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Cluster analysis of bacterial communities based upon DGGE profiles. Similarities were calculated using 
Pearson correlation. 
 
 
The total number of band positions detected in this DGGE gel was 192 and the number of 
DGGE bands per sample varied between 16 and 29. According to the dendrogram, there is 
a clear separation in 2 groups: communities of the wastewaters of hospital microbiology 
laboratory from those of hospitalization and the urban wastewaters.  
Profiles from the two sewage samples from the hospital microbiology laboratory (sample 
II) were located in one cluster due to their similarity (Pearson coefficient, 26.2%). These 
samples were collected from the same effluent in two different seasons. The temporal 
factor may not be more important than the spatial on the determination of this bacterial 
assemblage’s composition. Some of the bands detected in these two effluents suggest 
that the populations represented by these bands may persist and colonize the laboratory 
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settings. Although these bacterial populations can be discharged via wastewater, these 
bacterial populations may represent the dominant bacteria of the microbiology 
laboratory. 
 By the dendrogram, it is visible a high similarity (86.2%) between the bacterial 
communities from the pre- and post-treatment effluents of the WWTP in November 2014 
(samples III and IV). These samples were collected at the same day and at the 
dendrogram, they are located at the same cluster, sharing several bands. This result may 
suggest that the populations represented by these bands may persist from the effluent 
untreated to the final effluent of wastewater treatment plant. With this fact, it is possible 
to infer that there are not relevant changes in the structure of communities after 
treatment, leading us to believe that the treatment applied at this season may not have 
been effective at all or can have moderate removal efficiency. 
It is important to focus in the type of treatment applied in the WWTP of Cacia – 
secondary treatment. Secondary treatment is a biological process to treat wastewaters by 
using different types of microorganisms in a controlled environment and the organic 
matter is consumed by these microorganisms. Generally, several aerobic biological 
processes can be used, which differences are related with the way oxygen is supplied to 
the microorganisms and with the rate at which organisms metabolize the organic matter 
(31). 
According with DGGE profiles of samples III and IV collected in June 2015, it is visible that 
some of the dominant bacterial populations of the raw sewage were not present in the 
final treated effluent. This result is similar with what was obtained by Liu et al. (2007). 
They investigated by DGGE analysis the bacterial community structures in two WWTP 
with different processes and performance. The two WWTP revealed similar communities 
structures of raw sewage and activated sludge, but they had different populations in the 
effluents after treatment (117). 
The structure of microbial communities in raw sewage are less explored then the ones on 
activated sludge and on the final treated effluent. Bacteria from urban sewage are 
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considered to derive from the soil and sanitary wastes. Sanitary wastes are known to 
possess enteric bacteria from human or animal excretions. Rozen and Belkin (2001) 
demonstrated that some bacterial populations of enteric microorganisms were difficult to 
detect in aeration tanks due to their reduced survival in non-host environments, showing 
that many enteric bacterial population may decrease in receiving waters (118). As regard to 
soil bacteria, actinomycetes are the most abundant bacterial group in soils (119). 
Actinomycetes are active in the organic matter decomposition in soil and can degrade 
agricultural and urban wastes (120). However, when soil bacteria are mixed into 
wastewater, since the levels of oxygen decrease, it is expected that some of them 
become inactivated. So, it is reasonable that bacterial communities structures in pre- and 
post-treatment are different, and that the treatment applied reduces and changes the 
structure of these communities. 
As described in the dendrogram, although sample I (hospital wards effluent) is derived 
from the hospital environment, it is more related with samples III and IV (urban 
effluents), showing a clear difference compared with sample II that also belong to the 
hospital environment.  The microbiology laboratories (sample II) are characterized as a 
specific space with a particular design created based on the nature of the materials and 
samples handled, as well as the respective laboratory procedures. This design is essential 
to the safety of health professionals, hospital staff, patients, visitors and external 
individuals to the hospital. Restricted areas as the microbiology laboratory, comprise an 
invaluable and isolated part of the total health care and exams provided to patients, 
meaning that the access is restricted to health professionals (121,122). On the other hand, 
hospitalizations placements compromise both patients and workers of the hospital, but it 
also include the external people that enter, visit and exit these same zones, showing 
involve a larger flow of internal and external individuals to the hospital. Once 
hospitalization settings are not an isolated place as the microbiology laboratory, it is 
possible that bacterial communities of hospitalizations may depend on the amount and 
flow individuals, reason why the phylogenetic profiles can be more related with the 
profiles of municipal effluents.  
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Another fact that corroborates this relatedness between hospitalization and urban 
wastewater can be supported by the absence of a wastewater treatment station for the 
hospital effluents. These hospital effluents are discharged into urban network without a 
preliminary treatment, collected to the WWTP of Cacia and co-treated with the urban 
wastewaters (13,27). 
According to their origin of hospital wastewaters and urban wastewaters, it is expected 
differences in chemical and microbiological characteristics, such as some common 
macropollutants and major differences in the constitution and diversity of 
micropollutants, and then, reflecting different bacterial species composition. In this study, 
hospital wastewaters are co-treated with urban wastewaters at the WWTP of Cacia. In 
the first place, hospital effluents are discharged into urban network without a preliminary 
treatment. Consequently, it occurs the dilution of hospital effluents by total municipal 
sewage, mixing the compositions of each effluent and some components in the hospital 
wastewater may result in inhibition of the biomass and reduce the removal efficiency (123). 
It is also supposed that hospital effluents may have generally a weak microbiological load 
due to the wide use of disinfectants (124). However, the usage of these bactericides can 
result in negatives impacts on the biological treatments of WWTP (12,13). Even considering, 
the final diluted mixture of hospital and urban effluents discharged from the WWTP after 
the treatment processes, there will be always possible that certain substances may create 
promoting effects for the biological imbalance of aquatic ecosystem and surrounding 
environment (27). Some similarities between bacterial community structure of hospital 
effluents and municipal wastewaters, considering pre- and post-treatment effluents, can 
suggest the strong influence of the hospital discharges, as the efficiency of the treatment 
applied to the WWTP (125). 
In this study, it was not possible to determine the phylogenetic affiliation of DGGE bands, 
in order to achieve a clear characterization of the bacterial communities present in the 
studied effluents. If this strategy had been applied, the bands with higher intensity, the 
most frequent in samples or even the different bands that distinguish DGGE profiles, 
could had been excised for further analysis. Once the bands were excised from the gel, 
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the bands could be used for re-amplification with the original set and sequenced or 
blotted onto nylon membranes and hybridized to molecular probes specific for different 
taxonomic groups (3). To determinate the closest phylogenetic relatives, band sequences 
could be compared with other nucleotide sequences deposited in GenBank nucleotide 
data library using the BLAST software at the National Centre of Biotechnology Information 
website (http://www.ncbi.nlm.nih.gov/). 
DGGE patterns can be also examined using two indexes, in order to scope various aspects 
of microbial diversity. The Shannon-Weaver index of diversity, H (126) and the equitability 
index, E (127), assuming that each band corresponds to a single species and the intensity 
reflects the relative abundance of species in the community. The Shannon-Weaver index 
takes into account the richness (the number of different species in the sample) and the 
dominance (higher prevalence of certain species) of certain species in the studied profile. 
This index will be greater the higher the richness or the more uniform are the relative 
intensities to these species (126).  The equitability index of Pielou (E) varies between 0 and 
1. The minimum value indicates the pronounced predominance of certain species 
(relative intensity greater) up to a maximum which ensures the same relative abundance 
for all species (127). These indexes are calculated according to the following formulas: 
 
 
 
 
Where ni represent the intensity of a particular band in a given sample and N is the sum 
of the intensities of all the bands of the same sample; H is the Shannon-Weaver index 
calculated before and S is the number of DDGE bands used to indicate the number of 
species (128). 
 
Regarding with the studies of microbial communities, multivariate analyses have been 
also applied in microbial ecology. Multivariate analysis explores the relationship between 
dependent variables. The canonical correspondence analysis (CCA) is a multivariate 
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method whose aim is to explain the relationship between two sets of variables, looking 
for linear combinations for each of the sets of variables in order to maximize the possible 
correlation between groups (129,130). 
There are studies that through this multivariate analysis method, they compared 
changings in communities structures and percentage of cultivable bacteria resistant to 
antibiotics in function of time, type of water, antibiotic concentration and other operating 
parameters (32). In microbial ecological, is used to elucidate the relationships between 
biological assemblages of species and their environment (130). 
With these tools, future researches may be conducted in order to study the structure of 
bacterial communities, diversity, evenness and richness of bacterial communities of the 
study. 
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4.2 Presence of ARGS 
 
The ARGs conferring resistance to ß-lactam (blaTEM, blaSHV, blaCTX-M, and blaVIM) and class 1 
integron integrase (intI 1) were selected for PCR screening based on the following criteria: 
(i) clinically relevant genes; (ii) genes conferring resistance to frequently used β-lactam 
antibiotics (penicillins) and newer extended-spectrum ß-lactams (carbapenems and 
cephalosporins); and (iii) ARGs previously reported in mobile genetic elements (131,132). 
Occurrence of β-lactamase genes was detected by PCR amplification, using primer sets 
targeting conserved regions of β-lactamase encoding sequences. The occurrence of 
integrons in the microbial populations of wastewater samples was also investigated, 
specifically class 1 carrying the integrase gene intI. For each set of primers, annealing 
temperatures were optimized experimentally in order to obtain specific amplification. 
PCR conditions were rigorously tested using DNA and in all cases the observed size of the 
amplicons corresponded to the expected size. Positive and negative controls were 
included in each assay.  The PCR products were visualized on an 1.5% agarose gel.   
Table 5: Screening for genes. 
 blaCTX-M blaSHV blaTEM blaVIM intI 1 
N
o
ve
m
b
e
r 
2
0
1
4
 
H
o
sp
it
a
l I - + + + + 
II - - + - + 
W
W
TP
 III + + + + + 
IV + + + + + 
Ju
n
e
 2
0
1
5
 
H
o
sp
it
a
l I + + + + + 
II - + + + + 
W
W
TP
 III + + + + + 
IV + - + + + 
 Legend: + positive result 
                - negative result 
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By conventional PCR, we obtained a qualitative analysis of the antibiotic resistance genes 
present in hospital and WWTP wastewater.  
As summarized in Table 5, DNA sequences representing all antibiotic resistance genes 
studied were detected in all wastewater samples, revealing the presence of these 
resistance genes in the municipal environment as well in the hospital community.  
Almost all genes were detected in all effluents.  The most abundant ESBL types are 
represented by SHV, TEM and CTX-M, which have been described in hospital communities 
and in environmental samples (78,79,133). For a long time, the most prevalent ESBLs 
detected were variants of SHV and TEM families, which originated by single/multiple 
mutations on original SHV-1 and TEM-1 penicillinase (79). The blaTEM is one of the most 
frequently detected plasmid-borne antimicrobial resistance gene. However, in the last 
decade, blaTEM and blaSHV have become less frequent in clinics and have been replaced 
more recently by blaCTX-M (84,134). In recent years, a dramatic increase in these β-lactamases 
has been found worldwide in different compartments (73). 
In our study, blaTEM, blaSHV and blaCTX-M genes were detected. Several studies have 
reported the occurrence of ESBL-producing bacteria and the detection of TEM, SHV and 
CTX-M β-lactamases in hospital wastewaters, municipal wastewaters and WWTP effluents 
(135–138).  
According to our results, blaVIM gene was most frequently detected in urban and hospital 
wastewater. VIM is one of the most relevant metallo-enzyme, which has been mostly 
described in clinical settings and identified in clinically pathogens as Pseudomonas spp., 
Acinetobacter spp. and enterobacterial clinical isolates (139,140).  blaVIM emerged mainly 
associated to integrons that can be embedded in transposons (141). 
Marinescu and co-workers (2015) exanimated the resistance profiles of Gram-negative 
strains isolated from different types of wastewater and the receiving river and then 
estimated the contribution of these types of water to the environmental resistance 
reservoir. In their study, among Enterobacteriaceae strains analyzed, blaVIM was prevalent 
in Klebsiella sp. strains and E. coli strains isolated from hospital sewage effluent and urban 
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wastewater (142). The presence of VIM environmental producer species may be due to 
nosocomial selective conditions and contamination by hospital wastewaters. However, 
the detection of blaVIM in different environmental species from freshwater emphasizes the 
role of water as a reservoir for these genes and as a vector promoting their dissemination 
(134,143).  
The role of integrons in the capture and dissemination of ARGs is well recognized. These 
MGEs are frequently noticed in clinical pathogens as Acinetobacter baumannii, Shigella 
sp., Klebsiella pneumoniae, Pseudomonas aeruginosa, Aeromonas hydrophila and E. coli 
(91,144). Class 1 integrons are known to be widespread in clinical environment, where they 
usually harbor one or more gene cassettes responsible for resistance to a wide range of 
commonly used antibiotics (145). Like in clinical contexts, class 1 integrons are widespread 
outside clinical environment and they can provide selective advantages to cope with a 
range of environmental pressures (131,146). Several researchers focused on the abundance 
and distribution of class 1 integrons outside clinical environment have reported the 
presence of these integrons in compartments submitted to different degrees of 
anthropogenic disturbance (94,147–149). 
Rosser & Young (1999) studied the incidence of integrons in environmental bacteria. They 
screened the presence of class 1 integrons in estuarine bacteria. Their results appear to 
indicate that the prevalence of class 1 integron in bacteria from natural environment is 
lower than what was detected in clinical isolates, however, it is likely that the proportion 
of bacteria with integrons may be more prevalent outside clinical settings than previously 
estimated, since less than 1% of the bacteria in environmental samples are believed to be 
cultivable under laboratory conditions (149).  
In our study, we screened the occurrence of class 1 integrons in total DNA from 
wastewater samples, which was positive for both effluents, clinical settings and municipal 
sewage. Several studies had reported the occurrence of class 1 integrons in bacterial 
isolates obtained from hospital surfaces and wastewaters, livestock, fish farm, estuarine 
environments and other environmental sources, suggesting that integrons may be 
ubiquitous in nature (91,111,146,149). A future approach that could be performed is related 
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with the confirmation if the class 1 integrons quantified carry the resistance genes 
discussed. 
Some amplicons were not detectable in some samples from both municipal and clinical 
effluents. Conventional PCR is known as an approach that measures PCR amplification as 
it occur and in this study, we applied 30 cycles of temperature. However, these genes 
were subsequently detected in our analysis by qPCR. Since, qPCR measures the amount of 
accumulated PCR product at the end of the PCR cycles (normally 40 cycles), it was 
possible to detect the presence of these genes in lower quantities (150). However, these 
results will be further explained and discussed. 
Hospital effluents and other wastewaters from clinical settings may represent a risk to 
public health due to the presence of pathogens, chemicals and drugs that are not 
metabolized by patients (12,151). Hospital wastewaters analyzed in this study are directly 
discharged without pre-treatment to the urban sewage network, reaching the WTTP as 
urban sewage. WWTP are characterized by selective pressures for resistance to many 
toxic compounds, high organic content and high bacterial diversity providing a bond for 
mobile elements to mix between pathogens and environmental bacteria. Although 
hospital wastewaters have different origin and composition of urban effluents, once 
mixed, it become difficult to differentiate the resistance determinants between them by 
conventional PCR, since the WWTP collects the effluents from eight municipalities. 
Although many ESBL-encoding genes and mobile genetic structures have been described 
in the literature, this study did not carried out with the specific identification of β-
lactamase genetic determinants and integron gene cassettes by sequencing. As a future 
approach, it could be performed the purification of PCR product followed by their 
nucleotide sequencing and the comparison with other sequences deposited and available 
in the GenBank database using the basic local alignment search tool (Blast and ClustalW 
computer programs) (152). 
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4.3 Absolute quantification by qPCR of ARGs 
 
4.3.1 Standard curves and amplification efficiencies 
 
From the slope of each standard curve, the reaction efficiency (E) was calculated 
according to the equation:  
E= 10(-1/slope)-1 
The efficiency should be 100% (slope = -3.32), but this value is difficult to achieve. 
However, efficiency values between 90 and 110% are acceptable. The correlation 
coefficient (R2) of the curve should be ≈ 1 and the y-intercept value provides information 
about the theoretical limit of detection of the reaction (Ct correspondent to the minimum 
copy number that gives rise to statistically significant amplification) (153). 
According to the standard curves, the Ct value of unknown samples was used to calculate 
the number of corresponding gene copies. Each reaction was run in triplicate. High R2 
values (average 0.99844) and high values efficiencies (from 91.50 to 101.31%) obtained 
from the standard curves demonstrated the linearity and sensitivity of each qPCR assay. 
The efficiency, correlation coefficient, slope and y-intercept values are present in Table 6. 
 
Table 6: Efficiency, correlation coefficient, slope and y-intercept 
Target gene Efficiency (%) R2 Slope y-intercept 
blaCTX-M 98.64 0.9996 -3.355 39.344 
blaTEM 101.31 0.9983 -3.291 39.847 
blaSHV 91.50 0.9996 -3.544 38.992 
blaVIM 99.42 0.9997 -3.336 40.027 
intI1 101.69 0.995 -3.282 43.912 
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4.3.2 Evaluation of PCR inhibitors 
The presence of inhibitors was evaluated as described by Pei et al. (2006) through the 
calculation of the suppression factor. Each of the samples was spiked with 105 copies of 
quantification standard DNA and amplified together with the same set of non-spiked 
samples and control DNA.  
Table 7: Suppression factors calculated for a subset of spiked samples in qPCR assay of each ARGs 
 blaCTX-M blaTEM blaSHV blaVIM intl1 
Hospitalizations 1.51  1.13 1.50 7.29 0.17 
Microbiology Laboratory 2.06 1.05 1.03 0.69 8.57 
Pre-treatment 2.23 1.33 1.54 3.36 0.50 
Post-treatment 0.98 1.44 1.70 0.84 7.84 
 
 
Suppression factors were calculated for each sample according to the gene under study. 
As described in Table 7, suppression factors demonstrate variance between themselves. 
These values do not become clear and conclusive enough to evaluate the presence or 
absence of inhibitors. However, comparing the Ct values and the amplification curves of 
samples, of standard 105 copies and of the samples spiked with 105 of standard, it was 
visible that samples spiked with 105 of standard amplified earlier than the normal samples 
and closer from the standard 105 copies, indicating that inhibition was negligible. 
  
4.3.3 Abundance of resistance genes in hospital and urban 
effluents 
After analyzing and comparing the screening of the genes in both samples collected in 
November 2014 and June 2015, quantification of resistance genes was only performed in 
the samples collected in June 2015 due to the little volume available of the samples from 
November 2014. The five genes were selected for quantification by qPCR and gene copy 
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numbers were calculated per milliliter of sample in order to compare abundances in the 
different effluents (Table 8). 
Table 8: Abundance of genes (copy number gene/mL sample) 
 
 
 
Regarding to the total abundance of the genes for effluent (sum of abundance all genes in 
each effluents), hospital wards effluent was the highest, about 3.2059×108 copies/mL 
sample, followed by pre-treatment effluent with an abundance of 2.3277×108 copies/mL 
sample. Microbiology laboratory effluent was the lowest in total abundance (Table 8, 
Figure 14). However, these results were not statistically significant (Kruskal-Wallis, p = 
0.658). 
The total abundance for gene (sum of abundance of a gene in all effluents) varied greatly 
(Table 8, Figure 15). blaVIM abundance was the highest, about 3.0127×108 copies/mL 
sample, followed by intI1 with a total abundance of 5.4490×107 copies/mL sample. blaCTX-
M abundance was the lowest (Table 8, Figure 15). There was a statistically significant 
difference (Kruskal-Wallis, p = 0,003).  
  Hospital Wards 
Microbiology 
Laboratory 
Pre-treatment 
Post-
Treatment 
Total 
abundance 
for gene 
blaCTX-M 
Average 3.365×104 2.775×104 3.526×104 6.303×104 
1.5972×105 
s.d 7.648×102 2.946×103 2.056×103 7.042×103 
blaTEM 
Average 1.982×106 5.035×105 1.028×106 7.093×104 
4.2859×106 
s.d 1.482×106 5.165×105 3.068×106 2.002×105 
blaSHV 
Average 6.453×105 5.392×104 4.592×105 6.196×104 
1.2205×106 
s.d 6.186×104 1.003×103 1.424×104 7.743×103 
blaVIM 
Average 2.879×108 6.668×105 6.372×106 6.326×106 
3.0127×108 
s.d 1.630E×107 4.010×104 1.529×105 1.331×105 
intl1 
Average 3.002×107 6.681×106 1.538×107 2.403×106 
5.4490×10 
s.d 2.390×105 1.121×107 4.508×105 1.682×104 
Total abundance for effluent 3.2059×108 7.9331×106 2.3277×107 9.6275×106  
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Figure 14: Abundance for effluent 
 
 
Figure 15: Total abundance for gene 
 
In this study, it is also possible to differentiate the wastewaters between hospital 
(hospital wards and microbiology laboratory) and urban/municipal (pre- and post-
treatment) sources. As described in results and even without statistical significance 
(Kruskal-Wallis, p = 0.880), hospital effluents revealed a higher number of copies of the 
genes compared with urban effluents (Table 8, Figure 16). Although the WWTP of Cacia 
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receives effluents from eight municipalities, including other hospitals and 
domestical/urban wastes, probably untreated hospital discharges are a potential sources 
of antibiotic resistant bacteria and resistance genes reaching the WWTP. Hospital 
wastewaters are supposed to contain higher loads of resistant organisms, acting as 
suppliers of resistance into the environment (34,154,155). Conventional WWTP are normally 
not designed to treat hospital wastewaters and to remove associated contaminants  (156). 
In some European countries, different WWTPs have already been created, requiring a 
specific management and treatment of hospital effluents (157). 
With regard to the effluents from WWTP of Cacia, there was no statistically significant 
difference (One Way ANOVA, p = 0.411). However, the quantitative analysis 
demonstrated that the abundance of all genes decreased as a result of wastewater 
treatment (Figure 16). This result suggest that treatment applied of the WWTP may have 
a moderate removal efficiency and it also indicates the persistence of these genes in the 
natural water, meaning that WWTP discharge can support their spread into aquatic 
environments (107,158).  
The most abundant ESBL types are represented by blaCTX-M, blaSHV and blaTEM, being 
widely encountered in clinical therapy (79). blaCTX-M was less abundant in all sites, followed 
by blaSHV and blaTEM, indicating that may not be the dominant β-lactamase resistance 
genes in these places (One Way ANOVA, p = 0,016) (Figure 16).   
 
 
Figure 16: Abundance of genes per sample 
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blaCTX-M has been reported in the last decade  as the most  prevalent extended β-
lactamase (73). However, our results agree with a previous study about the occurrence and 
abundance of β-lactam resistance genes in wastewaters in which blaCTX-M was not even 
detected (107).  
Plasmid-mediated blaTEM and blaSHV have been found in different settings worldwide (79).  
Li and co-workers (2009) analyzed the antibiotic-resistance profile in environmental 
bacteria isolated from penicillin production wastewater treatment plant and the receiving 
river in China. They figured out that blaTEM and blaCTX-M were detectable in the biological 
treatment effluent of penicillin-producing wastewater (159). Yang et al (2012) 
demonstrated clearly the presence of TEM and other β-lactam resistance gene in 
activated sludge of different WWTPs in East Asia and North America (107). 
 It should be also stated that many of these studies quantified the bla genes in river water 
under the influence of wastewater discharges, but not directly in the treated effluent 
from WWTP (158,160,161). Another report related with antibiotic resistance was performed in 
source water and drinking water treatment plant in Ohio and Michigan, where it the 
water was tested before and after treatment. Although the bacterial concentration was 
lower during the treatment process, the prevalence of resistance to amoxicillin, rifampin, 
and chloramphenicol increased, showing that antibiotic resistance persists during the 
water treatment. They detected blaTEM and blaSHV in almost all samples, representing an 
evidence that these genes are commonly distributed through water systems (162). 
As regards the results of the abundance of blaVIM gene, there were statistically significant 
differences (Kruskal Wallis, p = 0.025). It is undoubtedly visible a huge abundance of 
2.8791×108 in wastewaters of hospitalization settings. In microbiology laboratory 
effluent, the blaVIM was the least abundant. The urban effluents (pre-and post-treatment) 
had a moderate abundance compared to the hospital effluents (Table 8). 
MBL are known to be encoded either by genes that are part of the chromosomal 
framework in some bacterial species (resident MBL) or by genes acquired by HGT 
- 60 - 
 
 
 
(acquired MBL) (86,163). The presence of blaVIM has been described as an acquired MBL, 
being mostly detected in strains of Enterobacteriaceae, Pseudomonas aeruginosa, 
Acinetobacter baumannii, and other Gram-negative non- fermenters (86). Several studies 
reported the occurrence of these acquired MBL–producing bacteria in hospital 
environments, revealing the occurrence of clonal spread and nosocomial outbreaks 
(140,164–168). Thus, once these hospitals represent reservoirs of MBL-producing pathogens, 
it can be expected the high abundance of these gene in these settings and consequently, 
in their wastewaters. 
The blaVIM gene has been mostly found in clinical settings and its role of in nonclinical 
habitats for bacteria that carry this gene has been less explored and probably this gene is 
less abundant in the environment (143).  Besides, it should be also taken into account the 
dilution of the hospital wastewater when it reaches the municipal sewage and when the 
municipal sewage mixes with all effluents from other cities collected at the WWTP (169). 
These facts corroborate our results, once the blaVIM abundance was lower. 
Regarding intl1 abundance, it was higher in hospitalization wastewaters than in 
microbiology effluent.  According to urban effluents, intl1 abundance was higher in pre-
treatment effluent than in the post-treatment (Figure 16).  There were no statistically 
significant differences (Kruskal-Wallis, p = 0.055). Class 1 integron are found in diverse 
locations, even in different plasmids and transposons, being described as ubiquitous in 
nature. They are described in pathogens isolated from clinical settings and pathogens and 
commensals isolated from livestock (170,171). 
The differences between hospital and urban wastewaters can be explained by the dilution 
factor of the effluents, as mentioned before. At the same time, the abundance reduction 
of intl1 in the outside of the WWTP reveals that the biological treatment by activated 
sludge reduce in fact the abundance integrons. These results agree with previous studies 
in which it was demonstrated by qPCR that activated sludge process reduce the 
abundance of integrons (172). Anthropogenic activities can lead to the release of abundant 
integrons and antibiotic-resistance gene cassettes, but in this study we cannot conclude 
no specific impact of hospital activities on the receiving environment. A previous study 
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investigated the role of hospital and urban effluents in resistance spread using intl1 gene 
as an integron marker, concluding that the WWTP with biological treatment could reduce 
the diversity of gene cassette arrays in the pre-treatment effluent (99). 
Wastewater treatment is not designed to remove or eliminate DNA contents and to 
decrease the abundance of resistance genes (100,173). The presence of low concentrations 
of antibiotics in WWTPs has been documented (174,175). The abundance of some genes may 
range during the treatment process as a consequence of selection driven by antibiotics 
and other antimicrobials that are inefficiently removed during the treatment (173,176). Even 
during the treatment, there are environmental conditions of activated sludge that 
promote the HGT between hosts due to the nutritional richness and high bacterial density 
and diversity. Bacteria carrying MGEs associated with resistance genes or that acquire 
resistance determinants by HGT, can sometimes increase the abundance during processes 
of water treatment (145).  
In this study, it was only quantified the abundance of the resistance genes and the copy 
number of each gene was calculated per mL of sample. However, it 16S rRNA gene 
quantification was performed, it could be possible to use the number of copies of 16S 
rRNA as a proxy for bacterial count to normalize the levels of β-lactamase encoding 
material depending on the bacterial count. 
The quantification of 16S rRNA genes allows to estimate the bacterial load per sample. 
With the view to avoid inconsistence among qPCR assays, including suboptimal efficiency, 
the 16S rRNA gene-normalized values could be used. The copy number of resistance 
genes and 16S rRNA gene for each sample could be calculated by plotting against the 
respective standard curve. The former would be divided by the later in order to order to 
normalize for any differences in input DNA concentrations between samples. Most of the 
studies concerning the occurrence and abundance of antibiotic resistance genes, report 
gene copy numbers normalized against mass (nanogram) of the extracted DNA samples, 
against the volume (milliliter) of sewage or sludge samples or the copy number of total 
16S rRNA (107,161,176,177). 
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5. Conclusions and Future Perspectives 
 
Hospital settings and health care facilities, where antibiotic use is more frequent and 
intensive, are regarded as important reservoirs of antibiotic resistance and nosocomial 
pathogens.  In addition, municipal sewage receives the bacteria previously exposed to 
antibiotics from private households, industries and hospitals, being recognized as 
receptors for antibacterial substances and antibiotic resistant bacteria. The microbial 
abundance, nutrients concentrations and selective pressures of antibiotics and other 
pollutants promotes the development of resistance in these environments and to HGT 
process.  
In this study, microbial communities from hospital wards and pre- and post-treatment 
effluents are phylogenetically related. The hospital wastewaters had the highest total 
abundance of the genes than the urban effluents. Of all genes blaVIM had a notable 
abundance due its high abundance in hospitalizations wastewater, followed by intl1.  
blaCTX-M, blaTEM, blaSHV had the lowest abundances. Regarding with the biological 
treatment applied in the WWTP of Cacia, once the abundance of the genes was lower 
after the treatment, it is predictable that the treatment can be moderately effective. Our 
results show that hospital settings tend to be a complex environment due to the high 
microbial diversity of commensal and nosocomial pathogens, the selective pressures 
created by antimicrobial use and the events of lateral gene transfer. The urban sewage 
network and the WWTP-Cacia represent a receptor of antimicrobial residues and 
antibiotic-resistant bacteria. 
Herein, it was not possible to perform the sequencing and identification of DGGE 
fragments. However, a following study could include this in the future and it would 
become clear to know exactly the bacterial populations that exist in hospital wastewaters 
and WWTP effluents. Additional approaches are needed to identify and quantify the most 
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phylogenetic groups, as quantitative slot blot hybridization or quantitative real time 
polymerase chain reaction (178).  
Further investigations are also needed to complete evaluate the potential resistome 
profile and role of Aveiro Hospital wastewaters and WWTP-Cacia effluents. The search 
should be extended to genetic determinants conferring resistance to other antibiotic 
groups, as well the possible links between MGEs carrying these genetic determinants. 
Culturing techniques could be applied to assess the diversity of cultivable bacteria and to 
determinate both resistance phenotypes and genetic content in resistance determinants. 
Culture-independent methodologies based on RNA analysis would be useful to estimate 
the expression of antimicrobial resistance genes in the environment.  
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Appendix 1 – DNA Extraction 
 
DNA extraction was performed with the Genomic DNA Purification Kit (MBI Fermentas, 
Vilnius, Lithuania), according with the manufacturer’s instructions. 
 
Thus, 400 μL of the Lysis Solution were added to the mixture, followed by incubation at 
65 ᵒC for 5 min. At this time, 600 μL of chloroform were added and by inversion the 
solution gently emulsified. The samples were centrifuged for 10 min at 13000rpm and the 
upper aqueous phase was transferred to a clean and sterile microtube. 1 volume of 
isopropanol was added and mixed gently by inversion, followed by an incubation of 15 
min ate 4 ᵒC. The mixture was centrifuged at 13000 rpm for 10 min and the supernatant 
completely removed. The pellet constituting the genomic DNA was gently dissolved in 
100 μL of the provided NaCl solution (1 M), until the pellet was completely dissolved. 2,5 
volumes of cold ethanol were added and the genomic DNA was allowed to precipitate 10 
min at -20 ᵒC. After centrifugation for 5 min at 13000 rpm, the ethanol was removed and 
the pellet washed with 250 µL of 70 % ethanol. This solution was removed by 
centrifugation 5 min at 13000 rpm and the pellet was allowed to dry completely at 50 ᵒC 
for 2 min. Finally, the extracted DNA was dissolved in 100 μL of TE stored at -20 ᵒC until 
further analysis. 
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Appendix 2 –Agarose Gels handling 
 
The analysis of DNA and PCR products were generally performed on agarose gel 
electrophoresis. The samples were mixed with 6X loading buffer in a proportion of 1:6 
(v/v) and loaded in a 1 % agarose gel. The gel was prepared with 1X of TAE buffer (Bio-
Rad) and EtBr (AppliChem) to a final concentration of 0.5 μg/mL added before pouring the 
melted agarose in the running tray.  In all gels a DNA marker was included, either 0.5 μg 
of the DNA Ladder Mix (Fermentas). Electrophoresis was generally performed at 120 V for 
the desired time (normally 30 min) or at 100 V during 50 min and the DNA was analysed 
under UV light and the image acquired in the ATTO image acquisition system.  
 
Solutions:  
Loading buffer 6X: 2.5 mg/mL of bromophenol blue, 2.5 mg/mL of xylene cyanol FF and 
30 % (v/v) glycerol; stored at 4 ᵒC.  
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Appendix 3 - Purification and concentration of PCR products 
 
Purifications of PCR products were performed using the NZYGelpure (NZYtech), according 
to the manufacturer’s instructions. 
The volume of the reaction mixture was transferred to a 1.5 mL microcentrifuge tube and 
five volumes of Binding Buffer were added and mixed well. This mixture was applied to an 
NZYTech spin column, incubated at room temperature for 2 min and centrifuged for 1 
min at top speed. The flow-through was discarded and 600 μL of Wash Buffer were added 
to the spin column. After 2 min of room temperature incubation, the column was 
centrifuge for 1 min and the flow-through was discarded. An additional 1 min 
centrifugation was performed to remove residual ethanol. The NZYTech spin column was 
then placed into a clean 1.5 mL microcentrifuge tube and 30 to 50 μL of sterile distilled 
water were added to the center of the column. The DNA-containing column was 
incubated at room temperature for 2 min and then centrifuged for 1 min to elute the 
DNA. The sample was stored at -20 ᵒC until further use. 
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Appendix 4 – Preparation and transformation of chemically 
competent E. coli cells 
 
i. Preparation of competent cells by calcium-chloride method 
Chemically competent cells were prepared using and adaptation of the procedure 
described by Sambrook and Russell (2001). The desired strain was inoculated in 10 mL of 
LB medium supplemented with the appropriated selective marker, overnight at 37 ᵒC, 180 
rpm.  The pre-culture (500 μL) was used to inoculate 50 mL of fresh LB medium 
supplemented with the appropriate antibiotic. The bacterial culture was grown at 37 ᵒC, 
180 rpm, to an OD600nm of approximately 0.3 and centrifuged at 4 ᵒC for 2 min at 6300 x 
g. The resulting pellet was washed with 13 mL of ice-cold 0.1 M MgCl2 and centrifuged as 
mentioned before. The cells were washed again with 25 mL of 0.1 M CaCl2 solution, 
incubated on ice for 20 min and centrifuged as above.  Finally the cells were resuspended 
in 1 mL of cryopreservation buffer (CaCl2 0.1 M, 15% (v/v) glycerol), 50 μL were 
distributed in 1.5 mL microcentrifuge tubes and stored at -80 ᵒC until use.  
 
ii. Transformations 
An aliquot of 50 μL of competent E. coli DH5α cells stored at -80 ᵒC were thawed on ice 
and the DNA was added (~5-100 ng of plasmid DNA or 5 μL of ligation reaction). The 
mixture was incubated in the 1.5 mL microcentrifuge tube on ice for 30 min and 
transferred to 42 ᵒC for 45 sec. The microcentrifuge tube was directly placed on ice and 
250 µL of LB medium was added. The cells were grown for 1 hour at 37 ᵒC, 180 rpm. 
Afterwards, approximately 100 μL of the transformation were finally spread on LB agar 
containing 100 μg/mL of ampicillin, 100 μg/mL of X-Gal and 0.5 mM of IPTG. The plates 
were incubated at 37 ᵒC overnight. 
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Appendix 5 – Extraction of plasmid DNA 
 
The extraction of plasmid DNA from E. coli was performed with the Miniprep NZYtech Kit, 
according with manufacturer’s instructions.  
Briefly, a bacterial culture was grown in LB medium with the appropriate selection agent, 
overnight at 37 ᵒC with aeration (180 rpm). 5 mL of this culture was centrifuged at 11000 
x g for 2min, the supernatant was discharged and the cells were completely resuspended 
in 250 μL of Resuspension Solution (A1). 250 μL Lysis Buffer (A2) were added and the tube 
was gently inverted until the solution became clear and viscous, followed for an 
incubation at room temperature for a maximum of 4 min. Neutralization was performed 
by the addition of 300 μL of the Neutralization Buffer (A3) and by the solution was mixed 
by inverting softly the tube and centrifuged for 10 min at room temperature. An NZYTech 
spin column was placed in a 2 mL collecting tube. The supernatant was transferred onto 
the column, avoiding the transfer of the white precipitate and centrifuged for 1 min at 
11000 x g. The flow-through was discarded and the column was placed back into the 
same collection tube. The DNA attached to the column was washed by the addition of 
500 μL of Wash Buffer (AY) followed by centrifugation for 1 min at 11000 x g and the 
flow-through was discarded. Another wash was performed by adding 600 μL of another 
Wash Buffer (A4, with ethanol previously added) followed by centrifugation for 1 min at 
11000 x g and the flow-through was once more discarded. Finally the column was 
transferred into a sterile 1.5 mL microcentrifuge tube and centrifuged for 2 min at the 
same speed to remove residual ethanol. 
The plasmid DNA was eluted by the addition of 50 μL of Elution Buffer (AE) to the center 
of the column, incubation at room temperature for 1 min at room temperature and 
centrifugation at 11000 x g for another 1 min. 
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Appendix 6 - DNA concentration – Qubit® (Invitrogen) 
 
The Quant-iTTM working solution was made by diluting the Quant-iTTM reagent 1:200 in 
Quant-iTTM buffer (DNA or RNA reagent and buffer according to the sample to be 
measured). 199 μL of the working solution were loaded into the assay tubes and 1 μL of 
sample was added (the final volume must be 200 μL). The mixture was mixed by vortexing 
2-3 s and incubated for 2 min at room temperature. The tube was then inserted into the 
QubitTM fluorometer and the concentration was calculated following the instructions on 
the screen. 
 
